CHIR-99021 (CT99021) HCl

Catalog No.S2924

CHIR-99021 (CT99021) HCl is hydrochloride of CHIR-99021, which is a GSK-3α/β inhibitor with IC50 of 10 nM/6.7 nM in cell-free assays; ability to distinguish between GSK-3 and its closest homologs Cdc2 and ERK2.

Price Stock Quantity  
USD 340 In stock
USD 90 In stock
USD 170 In stock
USD 570 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

CHIR-99021 (CT99021) HCl Chemical Structure

CHIR-99021 (CT99021) HCl Chemical Structure
Molecular Weight: 501.8

Validation & Quality Control

Cited by 66 publications:

7 customer reviews :

Quality Control & MSDS

Related Compound Libraries

CHIR-99021 (CT99021) HCl is available in the following compound libraries:

GSK-3 Inhibitors with Unique Features

  • Selective GSK-3 Inhibitor

    TWS119 GSK-3β-selective, IC50 of 30 nM.

  • Most Potent GSK-3 Inhibitor

    CHIR-98014 GSK-3α, IC50=0.65 nM; GSK-3β, IC50=0.58 nM.

  • GSK-3 Inhibitor in Clinical Trial

    Tideglusib Phase II for Alzheimer's disease.

  • Newest GSK-3 Inhibitor

    AZD1080 Orally active, brain permeable GSK3 inhibitor, inhibits human GSK3α and GSK3β with Ki of 6.9 nM and 31 nM, respectively.

Product Information

  • Compare GSK-3 Inhibitors
    Compare GSK-3 Products
  • Research Area
  • Inhibition Profile

Product Description

Biological Activity

Description CHIR-99021 (CT99021) HCl is hydrochloride of CHIR-99021, which is a GSK-3α/β inhibitor with IC50 of 10 nM/6.7 nM in cell-free assays; ability to distinguish between GSK-3 and its closest homologs Cdc2 and ERK2.
Targets GSK-3β [1]
(Cell-free assay)
GSK-3α [1]
(Cell-free assay)
Tie-2 [1]
(Cell-free assay)
FLT1 [1]
(Cell-free assay)

 View  More

IC50 6.7 nM 10 nM >5 μM >5 μM
In vitro CHIR-99021 shows greater than 500-fold selectivity for GSK-3 versus its closest homologs CDC2 and ERK2, as well as other protein kinases. Furthermore, CHIR-99021 shows only weak binding to a panel of 22 pharmacologically relevant receptors and little inhibitory activity against a panel of 23 nonkinase enzymes. CHIR-99021 induces the activation of glycogen synthase (GS) in insulin receptor-expressing CHO-IR cells with EC50 of 0.763 μM. [1] In addition to simulating the actions of insulin, inhibition of GSK-3 by CHIR-99021 (3 μM) increases free cytosolic β-catenin by 1.9-fold, mimicking the canonical Wnt signaling pathway in 3T3-L1 preadipocytes. During any of the first 3 days of differentiation, CHIR-99021 treatment inhibits the preadipocyte differentiation with IC50 of 0.3 μM by blocking induction of CCAAT/enhancer-binding protein α (C/EBPα) and peroxisome proliferator-activated receptor γ (PPARγ). [2] Unlike lithium chloride and AR-A014418, CHIR-99021 treatment does not reduce the viability of INS-1E cells even at high concentrations. Instead, CHIR-99021 robustly increases the rate of proliferation of INS-1E cells in a dose-dependent manner, and significantly inhibits INS-E cell death induced by high glucose and high palmitate in a concentration-dependent manner. CHIR-99021 promotes primary beta cell replication in isolated rat islets at concentrations as low as 1 μM, with 2-3 fold increase of cell replication at 5 μM of CHIR-99021 treatment. [3]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
3T3-L1M1X0bWZ2dmO2aX;uJGF{e2G7NHnPRmo{KM7:TR?=M4nnRlQhcA>?MVXEUXNQNEL4V2hKdmirYnn0d{BxemWjZHnwc4N6fGViZHnm[oVz\W62aXH0bY9vMlK4NVIxPTV{MEC=
insulin receptor–expressing CHO-IRNGTEeJBHfW6ldHnvckBCe3OjeR?=NGjnTIg2ODBibl2=NVfPcIZmOzBibXnuMVvEUXNQMmfmRYN1cX[jdHXzJGdtgWOxZ3XuJHN6dnSqYYPlJEhIWyl?NU[zd4xTOTJ4ME[0PVc>
H4IIEMkPQSpVv[3Srb36gRZN{[Xl?NET4NFAyOCEQvF2=MYGyOEBpNWfVO5pWTE2VTx?=NYG4[G82WmWpdXzheIV{KM7{LXPheIVvcW5iYXP0bZZqfHliYX7kJHRKWkViY3;ueIFqdmmwZzDwdo9ud3SncjDhZ5Rqfmm2eR?=Mk\1NVU{PTBzOUW=
Oct4/Sox2/Klf4-infected MEFsMX;GeY5kfGmxbjDBd5NigQ>?NHvZVXUyOCEQvF2=M2HUSFI5KGR?MUDEUXNQNGHV[3NRem:vb4Tld{BOTU[|IILldJJw\3KjbX3pcochXHKjboPkeYNm\CCkeTDPZ5Q1NCCVb4iyMEBidmRiS3zmOC=>NIXzVG4yQTh|OUC1OS=>
Sca-1+ HPCMl\WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIDNSYszKM7:TR?=M4XtTFYh\A>?MorpSG1UVw>?MorpV5lv\XKpaYP0bYNidGy7IIDyc41wfGW|IGPjZU0yM8LiSGDDJJBzd2yrZnXyZZRqd25iYX7kJINwdG:weTDmc5Ju[XSrb36geI9o\XSqZYKge4l1cCCHR1[=MlHWNlE3OjR|NEi=
HMC1.2MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkW3N|Ah|ryPM2fBRVczKGh?NGDiSJFFVVORMV;S[YR2[2W|IHPlcIwhe3W{dnn2ZYw>NGfQdpgzOjB|OUOwNS=>
Endothelial cell(EC)NXq1NZZxTnWwY4Tpc44hSXO|YYm=NFXL[VU{KM7:TR?=MkW3SG1UVw>?M{PhOnBzd22xdHXzJIVv\G:2aHXsbYFtKGOnbHygLGVEMSCmaX\m[ZJmdnSrYYTpc44>NXvsblR[OjJyNUKwNFY>
PANC1M33TdmFxd3C2b4Ppd{BCe3OjeR?=NXX0OnpHyqB3IN88US=>Mn6zO|IhcA>?NW\vZ29kTE2VTx?=NYjteIppXHKrZ3fldpMh[W5iYYDvdJRwfGmlIILld5BwdnOnM{T2[VIzOjBzMUi2
INS-1EMonQSpVv[3Srb36gRZN{[Xl?NHrKXVEzNjVizszNMmC4NlQhcA>?NGDndZpFVVORNYTTZZdzUW6mdXPld{BiKHKnZIXjeIlwdiCxZjDOVFEhd3[ncnX4dJJme3Orb36=NX3ke2FzOjJ2Mke3NFQ>
hiPSC-NPsM1m2dmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXOz5qCK|ryPNXXpeoV1PzJiaB?=NUDvUHBiTE2VTx?=NYGwTGVUUW6lcnXhd4V{KGOnbHygdJJwdGmoZYLheIlwdsLiMme2NlI3PDJ4OEe=
plateletsNGe5bHNHfW6ldHnvckBCe3OjeR?=NX7XSoJ{OTBizszNM1T4VlE2KG2rbh?=NICx[WFFVVORMV;JcoNz\WG|ZYOgeIhzd22kaX6tcYVlcWG2ZXSgdIxifGWuZYSgZYdoemWpYYTpc44h[W6mIFHUVEB{\WO{ZYTpc44>MnLjNlMzOzl6N{e=
DN3NHW0NVFHfW6ldHnvckBCe3OjeR?=MWmxNEDPxE1?M3X5b|k3KGh?M1rHWGROW09?M1;6Omlv[3KnYYPld{Bk\WyuIHTleoVtd3CvZX70JIFv\CCycn;sbYZmemG2aX;uNVPWZYZSOjN3Mk[5PFk>
embryonic stem cells (ESC)M4nXS2Z2dmO2aX;uJGF{e2G7MVizJOK2VQ>?MVSxNUBlM4rjOmROW09?MnXkVJJwdW:2ZYOgd4Vt\i2{ZX7le4FtKG:oIH7hx893\S22eYDlJI1wfXOnIHXtZpJ6d26rYzDzeIVuKGOnbHzzJEhGW0NrNEnPNXkzOzh2M{OxNi=>
H460MoPyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{Twd|UhyrWPMWqyOEBpMXrEUXNQNUfxSFFGWHKxbX;0[ZMh[2WubDDwdo9tcW[ncnH0bY9vM2TCWlI1OzZ5Nki4
H157NVPU[JdGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1PuSlUhyrWPMn7CNlQhcA>?NFXoc4tFVVORMn\RVJJwdW:2ZYOgZ4VtdCCycn;sbYZmemG2aX;uM1\OWFI1OzZ5Nki4
H460MUDBdI9xfG:|aYOgRZN{[Xl?MUe1JOK2VQ>?NEDodYozPCCqNFO2[3dFVVORMomwRZR1\W63YYTld{Bk\WyuIHHwc5B1d3Orcx?=NXvVb|ZWOjR|Nke2PFg>
H157NHLtOVhCeG:ydH;zbZMhSXO|YYm=NVfHdY9IPSEEtV2=M1vTPFI1KGh?MYPEUXNQMkPUSI9meyCwb4Sgd4lodmmoaXPhcpRtgSCjZn\lZ5Qh[XCxcITvd4l{NXLVOmJiOjR|Nke2PFg>
A549MnW2RZBweHSxc3nzJGF{e2G7NX22No5KPSEEtV2=NUCzUpFKOjRiaB?=M4rJNmROW09?NX\JcoVPUW6lcnXhd4V{KGOnbHygZZBweHSxc3nzMUWyOFM3PzZ6OB?=
Neural progenitor cellsNX;1TGZoTnWwY4Tpc44hSXO|YYm=MlTmN{DPxE1?MV:xNEBlM172b2ROW09?MX7JcoR2[2W|IHflcoVz[XSrb36gc4YhdmW3cnHsJJBzd2enbnn0c5Ih[2WubIO=MnHMNlQ3OzhyM{S=
ES-D3M{T4NGN6fG:2b4jpZ{BCe3OjeR?=MUKxNOKh|ryPMnvXN{BlMYjEUXNQM3;xS2lv\HWlZYOgcY9l\XKjdHWgZ5l1d3SxeHnjbZR6KHerdHigTWM2OCCxZjC0Mlkh|ryPMmPJNlQ4Pzl|NkW=
ES-CCEM1;DVGN6fG:2b4jpZ{BCe3OjeR?=MVexNOKh|ryPNV34[mlnOyCmMkLuSG1UVw>?NFTFWFBKdmS3Y3XzJI1w\GW{YYTlJIN6fG:2b4jpZ4l1gQ>?MWiyOFc4QTN4NR?=
ES-D3MoTySpVv[3Srb36gRZN{[Xl?NWW2NlV3PcLizszNNF\Jd4w{KGR?Ml\SSG1UVw>?NXLPNGlzW3S{b37ncJkhcW6mdXPld{B1cGViYXP0bZZqfHlib3[gW451N2KndHGtZ4F1\W6rbjDwZZRpf2G7M2PSeFI1Pzd7M{[1
ES-CCEMn[1SpVv[3Srb36gRZN{[Xl?M2XRUVXDqM7:TR?=MYSzJIQ>NYDudodpTE2VTx?=NGTLWZVUfHKxbnfsfUBqdmS3Y3XzJJRp\SCjY4Tpeol1gSCxZjDXcpQw[mW2YT3jZZRmdmmwIIDheIh4[Xl?MX:yOFc4QTN4NR?=
SW982MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MknHTWM2OD1yLkKxOFE3KM7:TR?=MVzTRW5ITVJ?
GCTNELqXGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGD4XnhKSzVyPUCuN|A3PzJizszNM32zRnNCVkeHUh?=
769-PNF\5TG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTBwNUi0PVkh|ryPNVrSeIpRW0GQR1XS
LOXIMVIM4flOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXPJR|UxRTBwNUi4N|Ih|ryPM4\neHNCVkeHUh?=
D-336MGM37KXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFT2SIVKSzVyPUCuPFQ3OiEQvF2=M{Lte3NCVkeHUh?=
S-117NFfs[2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYrKXGhyUUN3ME2wMlkzOTNzIN88US=>NGPZfFdUSU6JRWK=
D-247MGMlXJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3\odmlEPTB;MD65OFg2OiEQvF2=MlTpV2FPT0WU
TYK-nuM4LWW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX3XVJdTUUN3ME2xMlA4QTF{IN88US=>NXvORVc2W0GQR1XS
A498MlnDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2\hW2lEPTB;MT6zNFQ3QSEQvF2=M{H4RnNCVkeHUh?=
BCPAPNE\0b2FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH:0UJNKSzVyPUGuOlY5QThizszNNV7vcVNyW0GQR1XS
KYSE-180MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWDk[HNuUUN3ME2xMlczPzh6IN88US=>M3jie3NCVkeHUh?=
MIA-PaCa-2NWfZU5VOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn\YTWM2OD1zLke1PVc4KM7:TR?=NHTQSXpUSU6JRWK=
HCC1395MnPSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEHndFdKSzVyPUGuO|gzPzNizszNNEfqXZlUSU6JRWK=
RS4-11NUDvemJJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmHvTWM2OD1zLkm1OFE2KM7:TR?=MWTTRW5ITVJ?
NCI-H2122NX7ac5VOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVHJR|UxRTJwMke2PFQh|ryPMkP0V2FPT0WU
SNU-423M2e0[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmXmTWM2OD1{LkS5O|g4KM7:TR?=MUnTRW5ITVJ?
SK-LMS-1MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmrLTWM2OD1{Lk[0NVI5KM7:TR?=M2XKXHNCVkeHUh?=
RPMI-7951MknPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlLaTWM2OD1{LkewNVk{KM7:TR?=MX3TRW5ITVJ?
COLO-829NFu5fZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MofETWM2OD1{Lke2OVQh|ryPMYfTRW5ITVJ?
SCC-9NUm3SHpqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2LFSWlEPTB;Mj65OVQ5PSEQvF2=NYe0XJg5W0GQR1XS
A704NYXLNYVPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3\4WWlEPTB;Mz6wPFEzKM7:TR?=NH72OFVUSU6JRWK=
HOP-62NHvZ[HdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVq2XVBLUUN3ME2zMlM3ODV2IN88US=>M1[yRnNCVkeHUh?=
HCC1569NH3GUZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYDJR|UxRTNwNEizNFUh|ryPM130W3NCVkeHUh?=
A172M2THe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWHJR|UxRTNwN{W0PVgh|ryPMm[3V2FPT0WU
MOLT-16NF7QSGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3jkZ2lEPTB;Mz64PFU2PiEQvF2=NVXoRWU5W0GQR1XS
TE-15MmDlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEPXR2ZKSzVyPUOuPVU{PDNizszNMoL6V2FPT0WU
OE19M1\uO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnTITWM2OD1|Lkm2OFUyKM7:TR?=MUXTRW5ITVJ?
MHH-ES-1MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXnJR|UxRTRwMES1OFUh|ryPM4jX[XNCVkeHUh?=
NKM-1M2PVPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXLJR|UxRTRwMUO5O|Eh|ryPM4jzWXNCVkeHUh?=
RCC10RGBNV;1fXF1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUP3V3VzUUN3ME20MlI6PDd7IN88US=>M4fqd3NCVkeHUh?=
BxPC-3NFLRPWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVjNUXlHUUN3ME20MlcxOzlzIN88US=>NFnycnpUSU6JRWK=
ALL-POMn62S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVHJR|UxRTRwOEO4OVgh|ryPNGjqNlFUSU6JRWK=
SK-OV-3MoPZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Moq1TWM2OD12Lkm5N|Qh|ryPM37hZXNCVkeHUh?=
SW1710MoO3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWHJR|UxRTVwNEK0OVYh|ryPNYfFPIozW0GQR1XS
NCI-H2452NV\j[pJVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYmyZo1NUUN3ME21MlQ2PjJ6IN88US=>NYL3eZRZW0GQR1XS
D-392MGM3P2SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoHLTWM2OD13LkS5NVQ2KM7:TR?=M2HwbXNCVkeHUh?=
LB2518-MELM3Xpdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2jneGlEPTB;NT63NlYzPyEQvF2=NF7ObXBUSU6JRWK=
BL-41M1zzbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1i2fWlEPTB;NT64NVI3PiEQvF2=MVvTRW5ITVJ?
WM-115MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUfJR|UxRTVwOEG1NFkh|ryPMm\mV2FPT0WU
SK-MEL-2NIHMV|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1;Z[WlEPTB;Nj6zPFM1PCEQvF2=NISyUHZUSU6JRWK=
CGTH-W-1M1K3NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWHJR|UxRTZwNEG3JO69VQ>?MWjTRW5ITVJ?
BB65-RCCM4Dpdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV\JR|UxRTZwNUOxPVUh|ryPMVzTRW5ITVJ?
CAL-85-1M4fyTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MULJR|UxRTZwNkC5N|Yh|ryPNWnUW5ZPW0GQR1XS
RT-112MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoHoTWM2OD15LkG2OFU3KM7:TR?=NVrzbnAyW0GQR1XS
MC116NUX1Z3p[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEXwRXdKSzVyPUeuNlg3QTFizszNM2nUd3NCVkeHUh?=
G-361NE\N[nlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3vJV2lEPTB;Nz60OlU3OSEQvF2=MoHzV2FPT0WU
SW1417MnPFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVvSeld1UUN3ME23MlY1PTh2IN88US=>NH;JfG1USU6JRWK=
MV-4-11M1LLUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mli5TWM2OD16LkW0N|A1KM7:TR?=MYTTRW5ITVJ?
CAL-72MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFj0bYRKSzVyPUiuO|YyOTNizszNMkLqV2FPT0WU
MKN28NGDYW3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MljZTWM2OD16Lki4OVE3KM7:TR?=MkO5V2FPT0WU
MEG-01NX7XZW9ZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHnSTXhKSzVyPUiuPVkxPDNizszNMWnTRW5ITVJ?
ACHNM2jLR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVXJR|UxRTlwM{C1OFYh|ryPM4jzU3NCVkeHUh?=
NCI-H1755M1\BV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mni3TWM2OD17LkO5PVg3KM7:TR?=MXHTRW5ITVJ?
NCI-H64MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWPJR|UxRTlwNEKyOVUh|ryPNF;BWpJUSU6JRWK=
COLO-205MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVPJR|UxRTlwNEO4NlEh|ryPM1vwbnNCVkeHUh?=
CTV-1NWjTS2R5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2ezbWlEPTB;OT60N|g6PCEQvF2=M2fGV3NCVkeHUh?=
U-2-OSM13WPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVHJR|UxRTlwNEWwNFYh|ryPNIG4OopUSU6JRWK=
LB996-RCCNEjZWnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGP2VoFKSzVyPUmuOVI{QTdizszNM2XIPHNCVkeHUh?=
SK-N-DZNETYRmpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYnJR|UxRTlwNkW3OFIh|ryPM4LsSnNCVkeHUh?=
EFM-19MorGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3;B[2lEPTB;OT63OVU3PiEQvF2=NVjjS3Q6W0GQR1XS
DBTRG-05MGM4DQdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWH3NVViUUN3ME25Mlc4PzdizszNMl:yV2FPT0WU
U-118-MGMoLwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWDJR|UxRTlwOUS0OFQh|ryPNIqzcndUSU6JRWK=
LB1047-RCCNH30OZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mnf3TWM2OD17Lkm5O|k5KM7:TR?=M120WnNCVkeHUh?=
NCI-H28M{HYe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV;JR|UxRTFyLkS0NVMh|ryPNYDpb4hmW0GQR1XS
MZ2-MELMn7hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVnJR|UxRTFyLkS2O|ch|ryPMWXTRW5ITVJ?
M059JNVXpV3BDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFTDfmdKSzVyPUGwMlYyODJizszNMVPTRW5ITVJ?
HT-3MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYXJR|UxRTFyLk[xO|kh|ryPNXzuRYw3W0GQR1XS
SNU-387NYjjTJJbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4OzO2lEPTB;MUCuO|I{PSEQvF2=MYfTRW5ITVJ?
NCI-H526NUPKdHdGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXnXVFNmUUN3ME2xNU4yOzZ3IN88US=>MYPTRW5ITVJ?
HELM4rsO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NITIW4VKSzVyPUGxMlY2PzlizszNNHzZcotUSU6JRWK=
PA-1MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV\JR|UxRTFzLkmzJO69VQ>?NGOyZ3FUSU6JRWK=
PC-14MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2\ERWlEPTB;MUKuN|I1KM7:TR?=MVPTRW5ITVJ?
C8166M1H0RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MojlTWM2OD1zMz6yN|E5KM7:TR?=NEDIUo5USU6JRWK=
NCI-H82NX3yfY5wT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV3JR|UxRTF|LkK5NFkh|ryPMljxV2FPT0WU
DSH1NVPHcWlpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWfJR|UxRTF|LkO4O|kh|ryPNUHBcnRiW0GQR1XS
T98GNWTycop5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml[4TWM2OD1zMz60O|E4KM7:TR?=MV7TRW5ITVJ?
KU812MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV;WO2pyUUN3ME2xN{42OTd3IN88US=>NF;ZTGVUSU6JRWK=
SW48MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX3oeYE1UUN3ME2xN{44OjZ3IN88US=>MXTTRW5ITVJ?
MEL-HOMlntS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnzpTWM2OD1zMz64PFI6KM7:TR?=NXW5R5JEW0GQR1XS
SF539MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUnJR|UxRTF2LkCxNVYh|ryPM1zLb3NCVkeHUh?=
NB1NUD4N3NCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3nCW2lEPTB;MUSuNVk{PSEQvF2=MWHTRW5ITVJ?
ST486NXPCNYJ6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnPoTWM2OD1zND6yNlUyKM7:TR?=MWnTRW5ITVJ?
LoVoNEL2e5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NULkU5VUUUN3ME2xOU4zPjV7IN88US=>NWS1PHJLW0GQR1XS
NH-12NWLDVXAxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWjJR|UxRTF4LkCwPVch|ryPMlXnV2FPT0WU
CCRF-CEMNXrnd2hDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmPMTWM2OD1zNj62O|AzKM7:TR?=MlPKV2FPT0WU
DaudiM1f1dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmC3TWM2OD1zNz62NVQ6KM7:TR?=NFPrd5lUSU6JRWK=
SIMAMnzBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFnCSlhKSzVyPUG3MlkyOThizszNMXPTRW5ITVJ?
8305CNFrJPG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{G0c2lEPTB;MUiuOVMxPSEQvF2=NV\2bFF1W0GQR1XS
EM-2MnLOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlviTWM2OD1zOD62NlQ5KM7:TR?=NYD3WYNrW0GQR1XS
SNU-449M1z2Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXTJR|UxRTF6LkexOUDPxE1?MWrTRW5ITVJ?
A101DMWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1[ycmlEPTB;MUmuNlQ{KM7:TR?=MXHTRW5ITVJ?
MHH-NB-11NYG1VZZRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWHkR2ZLUUN3ME2xPU42OzR{IN88US=>M2D2SXNCVkeHUh?=
BeckerMnvJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIXPbYJKSzVyPUKwMlE4PzdizszNNIe2cplUSU6JRWK=
NCI-H727M37vUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXvJR|UxRTJyLkKxOlkh|ryPMX7TRW5ITVJ?
HCC1187Mk\aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkTmTWM2OD1{MD6zOVg6KM7:TR?=M1vtS3NCVkeHUh?=
KYSE-450NYH2PJNET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGCy[HFKSzVyPUKxMlU{PTRizszNMnGzV2FPT0WU
SK-MEL-28MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1HpdGlEPTB;MkGuOlg3OyEQvF2=M2\B[XNCVkeHUh?=
BPH-1M1T6bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2j4cmlEPTB;MkGuO|A{PSEQvF2=NITMSXVUSU6JRWK=
EoL-1-MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVTJR|UxRTJzLkizPFUh|ryPNWLSSINkW0GQR1XS
TGBC24TKBM3W2WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVPaNppYUUN3ME2yNU45QTV5IN88US=>NXKwPXJrW0GQR1XS
KARPAS-299NESwSXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml70TWM2OD1{Mj6xPVU1KM7:TR?=Mn7UV2FPT0WU
SW684NFOzWotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{jpbGlEPTB;MkKuNlg2QCEQvF2=NHGyNHFUSU6JRWK=
RXF393MlntS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4TLe2lEPTB;MkKuOlA3QCEQvF2=M2jo[XNCVkeHUh?=
LS-513MmDxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1zNdGlEPTB;MkKuOlE6OiEQvF2=MnriV2FPT0WU
KURAMOCHINHr0VGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4\3O2lEPTB;MkKuO|A3QSEQvF2=NYP1U445W0GQR1XS
GI-1NIrqOIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVrJR|UxRTJ{Lke4OFEh|ryPMW\TRW5ITVJ?
M14M13VU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEG1bWxKSzVyPUKzMlEyOzJizszNNWfOfIdnW0GQR1XS
REHNHLJbFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MY\JR|UxRTJ|LkG2PVkh|ryPMXzTRW5ITVJ?
K5MoniS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml7tTWM2OD1{Mz61OFg3KM7:TR?=NHuwd5VUSU6JRWK=
PANC-10-05M2PwbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{jmTWlEPTB;MkSuNFg6QCEQvF2=M3T2THNCVkeHUh?=
HMV-IINHSwNXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmnaTWM2OD1{ND6yNVY{KM7:TR?=MWfTRW5ITVJ?
NCI-H1963NVnHUmFvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGPlVmpKSzVyPUK0MlI5OzlizszNMlrVV2FPT0WU
LU-139MkDQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NG\MSWRKSzVyPUK0Mlg{PSEQvF2=MXzTRW5ITVJ?
KASUMI-1MmDOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUfJR|UxRTJ2LkmzNlgh|ryPNVrUeZY1W0GQR1XS
RO82-W-1NUfUdHF3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFS5blNKSzVyPUK2Mlc{PzdizszNMnTaV2FPT0WU
NCI-H1770NUXyWZdyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVPOd2JZUUN3ME2yOk45QTh4IN88US=>MnvVV2FPT0WU
SNG-MMofVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV7JR|UxRTJ5LkKyO|Eh|ryPNUP6TnlFW0GQR1XS
KLEM17CU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mm\pTWM2OD1{Nz6yOVY2KM7:TR?=NIfqd5NUSU6JRWK=
NCI-H2170NXLyRpZET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYLzd|lRUUN3ME2yO{42Ojh{IN88US=>NG\FN29USU6JRWK=
COLO-792MoDhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV;oNHhiUUN3ME2yO{44PzJ6IN88US=>MXLTRW5ITVJ?
ES8NXvMOZhrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlzQTWM2OD1{Nz63PFE1KM7:TR?=MlK1V2FPT0WU
MC-CARMkDqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGH0bIVKSzVyPUK3Mlc6ODdizszNNFTXO2hUSU6JRWK=
SU-DHL-1MmXWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{Dy[mlEPTB;MkeuPVQ4PCEQvF2=NG\uTphUSU6JRWK=
OAW-28NVHGXGVbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NETxN|FKSzVyPUK4MlAxPTJizszNMWXTRW5ITVJ?
C32MkD0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFO1Oo1KSzVyPUK4MlA5OjZizszNMoPMV2FPT0WU
SW872MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIq1[mlKSzVyPUK4MlU{OjZizszNNYnUUJY1W0GQR1XS
JiyoyeP-2003M2LKZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFXGU4dKSzVyPUK5MlY4OTlizszNMYrTRW5ITVJ?
A204M1PFeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFTiU3dKSzVyPUK5MlY5OjhizszNMYLTRW5ITVJ?
IST-MES1NETqW4NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M173SmlEPTB;MkmuO|A6OiEQvF2=Ml\FV2FPT0WU
LCLC-103HMoXKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX7JR|UxRTNyLkKwOVkh|ryPNGm1ZY1USU6JRWK=
CAKI-1MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX3JR|UxRTNyLkK2OVYh|ryPNF7XOGZUSU6JRWK=
NALM-6M2\hOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4Ll[mlEPTB;M{CuOFk3PSEQvF2=M1\nNHNCVkeHUh?=
SK-MM-2MlHGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV3uZ5lyUUN3ME2zNE46Pzl{IN88US=>MVvTRW5ITVJ?
LB373-MEL-DMWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M33acmlEPTB;M{GuNFA1PyEQvF2=MmDYV2FPT0WU
CAS-1MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVHJR|UxRTNzLke2OlUh|ryPMlXTV2FPT0WU
KNS-42MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHW5ZWdKSzVyPUOxMlg3PjJizszNNGPlenVUSU6JRWK=
SW948NITnc3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXrJR|UxRTN{Lke1OFgh|ryPM1fNdXNCVkeHUh?=
HCC1143MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MknSTWM2OD1|Mj63PVc6KM7:TR?=NIqwbnVUSU6JRWK=
NCI-H1648NGDnXVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWDIcVdNUUN3ME2zNk45PDZ5IN88US=>NH71XGNUSU6JRWK=
RVH-421MlfQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUPyfGVUUUN3ME2zN{4yPjhizszNNFzKN4VUSU6JRWK=
KU-19-19NG\ZXllIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUTVZW9kUUN3ME2zN{44PTN2IN88US=>MX;TRW5ITVJ?
PFSK-1NUGzbXBET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVnJR|UxRTN2LkmyOFEh|ryPMYTTRW5ITVJ?
TK10NF;QcVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHHGcGpKSzVyPUO1MlE{OjJizszNNIPwTXFUSU6JRWK=
IGROV-1M2HGT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3PuNmlEPTB;M{WuN|QyPiEQvF2=NYLIfXBNW0GQR1XS
EFE-184NXWycGpUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml:3TWM2OD1|NT65NVch|ryPNEKz[o5USU6JRWK=
8505CNWTuN29qT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVvibI17UUN3ME2zOU46Ojl2IN88US=>NVP2Zpp[W0GQR1XS
SK-UT-1MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWT4fIU4UUN3ME2zOk4{OzNzIN88US=>M1\rc3NCVkeHUh?=
MKN1NWHOeHpIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn62TWM2OD1|Nj64OFQ1KM7:TR?=MXLTRW5ITVJ?
no-10NI\LR3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYLJR|UxRTN6LkGyPVQh|ryPNGO3UJdUSU6JRWK=
HT-144MofpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1;5UWlEPTB;M{iuNlU4PSEQvF2=NXLPO5JWW0GQR1XS
CMKNWPnOFROT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1L2W2lEPTB;M{iuOFE3OiEQvF2=Moj0V2FPT0WU
KM12MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX;JR|UxRTN6LkW5PVgh|ryPNH\O[2xUSU6JRWK=
HCC2218MmTKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2HoWWlEPTB;NECuOVg1QSEQvF2=M1zkTXNCVkeHUh?=
BE-13M{\IfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1fNT2lEPTB;NEGuOFQ4OyEQvF2=NVHZdmduW0GQR1XS
SK-CO-1M{LSZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYnPUGRiUUN3ME20NU44PzV3IN88US=>M4jYXnNCVkeHUh?=
MPP-89NF\BcnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4C3Z2lEPTB;NEGuPVIyOSEQvF2=M{L4PXNCVkeHUh?=
NYMXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXjZc3Y2UUN3ME20Nk4yQDBzIN88US=>NVnxRWl1W0GQR1XS
IST-MEL1M1LjNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVnOcJNCUUN3ME20Nk43QTN6IN88US=>M2j2UnNCVkeHUh?=
HCT-116MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2LBeGlEPTB;NEOuNlA6QSEQvF2=MX;TRW5ITVJ?
LB831-BLCMmqxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3rjV2lEPTB;NEOuOlk4KM7:TR?=MlnxV2FPT0WU
TE-8M1\JS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYHYN49WUUN3ME20N{44QDl3IN88US=>NWf1N4VwW0GQR1XS
SRMVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIDwUJZKSzVyPUSzMlg3PzNizszNMWjTRW5ITVJ?
ESS-1MnTFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXjJR|UxRTR2LkKwOlIh|ryPM3jJS3NCVkeHUh?=
KYSE-270NFTmUJpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{T4Z2lEPTB;NEWuNFQ{PyEQvF2=M4jyUXNCVkeHUh?=
H4M33pbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHiwZoRKSzVyPUS1MlMzQTZizszNMlvSV2FPT0WU
COLO-800M131fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3;GSmlEPTB;NEWuOVg6QCEQvF2=M3;VWnNCVkeHUh?=
Ramos-2G6-4C10M2fwWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWPpZWdHUUN3ME20Ok4xPzV3IN88US=>NX:wNGJDW0GQR1XS
no-11MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXfJR|UxRTR4LkKwN|Eh|ryPMV;TRW5ITVJ?
UACC-62M1PGVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXXTPHgxUUN3ME20Ok45PjB6IN88US=>NHrWc3lUSU6JRWK=
D-542MGNGXj[4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NI\HR5pKSzVyPUS3MlQ2QDlizszNNYXGPHltW0GQR1XS
NCI-H747MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGfiemFKSzVyPUS3MlczPjRizszNM13hT3NCVkeHUh?=
HCC2998MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4TBZWlEPTB;NEiuNlk5OiEQvF2=M4DxSXNCVkeHUh?=
SNB75NFXnUIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4TE[mlEPTB;NEiuOFEyQCEQvF2=NFLLVpRUSU6JRWK=
COR-L105NXzkR296T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4HrN2lEPTB;NEiuPVc{KM7:TR?=NXPkXIpjW0GQR1XS
SNU-C1MoK2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1rTOGlEPTB;NEmuN|IxPyEQvF2=M1zi[nNCVkeHUh?=
LC4-1M2LEbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEP4RWVKSzVyPUS5Mlg6OTJizszNMWXTRW5ITVJ?
KS-1M2nkRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYDJR|UxRTVyLkKyNlUh|ryPM3LxTHNCVkeHUh?=
NCI-H1793NVrSSXdsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEHrS4RKSzVyPUWxMlI{OSEQvF2=NX[3cHVOW0GQR1XS
NCI-H1650M{WyO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3nLU2lEPTB;NUGuOVg1QSEQvF2=M3H5UHNCVkeHUh?=
MCF7NUSweoJKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYjJR|UxRTVzLke1OVQh|ryPMkHmV2FPT0WU
SK-N-ASMl3uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWPJR|UxRTVzLkiyPFEh|ryPNVvQfGl1W0GQR1XS
SW837MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkDnTWM2OD13MT65O|g2KM7:TR?=M175W3NCVkeHUh?=
DBMmfqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHT4ellKSzVyPUWxMlk5PTVizszNM1v0PHNCVkeHUh?=
CESSMVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MofHTWM2OD13Mj6xOFUh|ryPMVPTRW5ITVJ?
CHP-126NYDWNWJYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH;lOJFKSzVyPUWzMlUyPjlizszNM1XxdHNCVkeHUh?=
COLO-824MlTkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVjJR|UxRTV|Lk[5O|Yh|ryPNIDmWXpUSU6JRWK=
MG-63M{LEZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH7jSHNKSzVyPUWzMlk{QDFizszNMmTWV2FPT0WU
KGNMoDNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3Lk[mlEPTB;NUOuPVU6KM7:TR?=MV7TRW5ITVJ?
697NFrMdYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVvJR|UxRTV2LkG1OVUh|ryPNHL2No5USU6JRWK=
MC-IXCMXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWm0dVk6UUN3ME21OE41OzZ2IN88US=>M1LFW3NCVkeHUh?=
A375NHTn[m5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEX3S2dKSzVyPUW0MlgxPTlizszNMkW4V2FPT0WU
LXF-289NUfHSXU4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoLKTWM2OD13NT61NFY3KM7:TR?=M4fNd3NCVkeHUh?=
ES6NW\uWGZqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2KwRWlEPTB;NUWuPFg6QSEQvF2=NVWwNGRnW0GQR1XS
DV-90M{LmXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYjCXnd6UUN3ME21OU45QTF5IN88US=>M4DVTXNCVkeHUh?=
RCM-1MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUfONnQ{UUN3ME21Ok4xODd6IN88US=>NF;yOnBUSU6JRWK=
NCI-H2405NGXkdIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH21VIZKSzVyPUW2MlE3QTNizszNNILucllUSU6JRWK=
DoTc2-4510MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYjJR|UxRTV4Lk[wOVch|ryPNFKyOm1USU6JRWK=
RPMI-8866M1jCTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MljTTWM2OD13Nz6yOFEzKM7:TR?=NVe0NHpTW0GQR1XS
BV-173NG\VVZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MULJR|UxRTV5LkWxOFIh|ryPNYD2SJZMW0GQR1XS
LCLC-97TM1M3Xrfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{jCZ2lEPTB;NUmuNFU2OyEQvF2=MVPTRW5ITVJ?
HT-1376MoLiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MY\JR|UxRTV7LkC5NlEh|ryPM4rnXnNCVkeHUh?=
ACNM2PMdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NITj[JRKSzVyPUW5MlE2QDdizszNMlrlV2FPT0WU
LU-134-AMmftS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXPJR|UxRTV7Lk[wNVYh|ryPNXjV[Gw6W0GQR1XS
SiHaMVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MY\JR|UxRTV7Lk[0PFch|ryPMkX5V2FPT0WU
EKVXM3fHTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{LWdGlEPTB;NkGuOFk2QCEQvF2=MnnZV2FPT0WU
NMC-G1NVzVbJY3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mnv6TWM2OD14MT65NlQzKM7:TR?=MoLtV2FPT0WU
NCI-H1734Moe3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGG5R29KSzVyPU[xMlk3PjNizszNNG\qTZpUSU6JRWK=
K-562NFn5NWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2LDZmlEPTB;NkKuNlQ2OiEQvF2=NG[zRWtUSU6JRWK=
T-24NVj4TIlbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHnsTFFKSzVyPU[yMlcyOjZizszNMWXTRW5ITVJ?
SCHM4XQ[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWXJR|UxRTZ2LkKzOVEh|ryPM2DZOnNCVkeHUh?=
AN3-CAM2nJSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4D0SWlEPTB;NkSuN|A{PSEQvF2=NUH5SmxGW0GQR1XS
MFE-296M13jN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYHJR|UxRTZ2LkS0O|Mh|ryPMmG0V2FPT0WU
HuCCT1M3X4c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M363T2lEPTB;NkeuNFM4PCEQvF2=M4\JRXNCVkeHUh?=
NCI-H1703NV;wb4Y3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGTORXVKSzVyPU[4MlEyPzFizszNNYL0PYp{W0GQR1XS
C-4-IINGTmb25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoDBTWM2OD14OT6zOlA4KM7:TR?=MmTyV2FPT0WU
NCI-H2342NY\0XJBLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1rJc2lEPTB;NkmuN|k3OSEQvF2=Mn;UV2FPT0WU
Hs-578-TM2DyXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWDJR|UxRTdyLkOg{txONFO4Ro9USU6JRWK=
HCC1806M{fFeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn;rTWM2OD15MT60OVg4KM7:TR?=MUnTRW5ITVJ?
EW-16NYLvR2czT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{\lUGlEPTB;N{GuO|QyPSEQvF2=NV3Rd3JHW0GQR1XS
KALS-1MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEPLfINKSzVyPUezMlU1PzVizszNMXXTRW5ITVJ?
RT4MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkLmTWM2OD15Mz61O|QzKM7:TR?=NXzXUWRPW0GQR1XS
LS-411NNWPKSXhmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmHnTWM2OD15ND6yOVI5KM7:TR?=M4XUTHNCVkeHUh?=
SK-MEL-1M4TWcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4DZVWlEPTB;N{WuPFAyQSEQvF2=NVnPR3h4W0GQR1XS
8-MG-BANGHHcHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXfJR|UxRTd4LkGwPVYh|ryPMl7FV2FPT0WU
HSC-3NFz2dmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFfyWmZKSzVyPUe3MlAzQDJizszNNH;pfllUSU6JRWK=
NB6M2L4UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHrPRlVKSzVyPUe4MlEzQTlizszNNUfQTXM3W0GQR1XS
PANC-03-27NUXl[2hoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEToO2pKSzVyPUe4MlQ{PSEQvF2=M2Lmb3NCVkeHUh?=
KP-N-YSMXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml\kTWM2OD15OD61PFc5KM7:TR?=MornV2FPT0WU
SF295MlPJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFnuPFhKSzVyPUe5Mlk2PTNizszNMn7hV2FPT0WU
HCE-TM4HI[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkTyTWM2OD16MD6xOVg5KM7:TR?=MV3TRW5ITVJ?
KYSE-410NUPEUFdWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUjJR|UxRThyLkK4OVch|ryPNHHVPFhUSU6JRWK=
NB12NFTKXVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1ziOGlEPTB;OECuPVM3QSEQvF2=NVvoSG5GW0GQR1XS
NCI-H661MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2nJZWlEPTB;OEGuN|Q1KM7:TR?=MV7TRW5ITVJ?
NCI-H1417M1fJZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWPJR|UxRThzLkSzOlgh|ryPMnzsV2FPT0WU
KMOE-2NWXEU4k5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3rRZWlEPTB;OEGuPFU{OSEQvF2=M1jWRnNCVkeHUh?=
SW1573M{frXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{XWUGlEPTB;OEKuOVg6OyEQvF2=Mmi0V2FPT0WU
BFTC-905NWLFOoQ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFfKPWhKSzVyPUi0MlAyPzJizszNNFzCXG5USU6JRWK=
SBC-1NH\qVGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2DaNWlEPTB;OESuNFIxQCEQvF2=NITtT3dUSU6JRWK=
MDA-MB-175-VIIMX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEnmTppKSzVyPUi1Mlc1OjZizszNMkXBV2FPT0WU
TE-12NW\BdXhMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWfJR|UxRTh7LkO3OFEh|ryPM3zUcnNCVkeHUh?=
NCI-H650NWfnTppMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmX4TWM2OD16OT64O|I1KM7:TR?=NHTCc4xUSU6JRWK=
C-33-ANWW3bWJyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGn3eZFKSzVyPUmwMlU1KM7:TR?=M1PaWnNCVkeHUh?=
MZ7-melNIjXPYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlvOTWM2OD17MT6yOlc3KM7:TR?=NX3CPXdTW0GQR1XS
BOKUNWKzPVh7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFroVYRKSzVyPUmyMlY6PTdizszNMXHTRW5ITVJ?
CAL-33M{XqNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGOyeGFKSzVyPUmzMlA3ODFizszNMmDLV2FPT0WU
23132-87NV\pTlVRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEH0Z5ZKSzVyPUmzMlE3QCEQvF2=NYLWNJU4W0GQR1XS
J82MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGfKfVdKSzVyPUmzMlc5OTFizszNNYHUUZN2W0GQR1XS
MZ1-PCNGjMNVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml62TWM2OD17ND61PVg1KM7:TR?=NELXXnFUSU6JRWK=
MEL-JUSOMWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3jieGlEPTB;OUSuPVU1KM7:TR?=NGfoVFdUSU6JRWK=
RMG-IMorUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVLJR|UxRTl3LkGwO|Ih|ryPMlLKV2FPT0WU
A2058M3jGPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUfHfohHUUN3ME25OU41PjF5IN88US=>NVvzbmVbW0GQR1XS
Caov-4NYTOdmt5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3PBUWlEPTB;OUWuOlg2KM7:TR?=Mo\GV2FPT0WU
OS-RC-2MoG0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NInJU5dKSzVyPUm3MlQ3OSEQvF2=NGXSVmNUSU6JRWK=
MKN7M37DRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEGyRnVKSzVyPUm3Mlc1OzlizszNMYLTRW5ITVJ?
U-698-MMUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4OzTGlEPTB;OUiuPVQ5QSEQvF2=MlfPV2FPT0WU
PC-3NGGxU3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH\QXppKSzVyPUm5MlA2PjRizszNNVTWVpMyW0GQR1XS
NCI-H292M2f5eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn7QTWM2OD17OT6zNFA1KM7:TR?=MVnTRW5ITVJ?
IGR-1M3LheWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUDJR|UxRTl7LkOxNVkh|ryPNFLCOWVUSU6JRWK=
MewoNYTZZoZyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYHTXIJvUUN3ME25PU42PjB|IN88US=>NGf3fo5USU6JRWK=
LU-65NFzaTnVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{HSVmlEPTB;MUCxMlA5OSEQvF2=Ml;iV2FPT0WU
Saos-2MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3y5cmlEPTB;MUCxMlQ{PyEQvF2=MYTTRW5ITVJ?
TE-11M1vUcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkTqTWM2OD1zMEGuO|I1KM7:TR?=NHvHWI9USU6JRWK=
SK-MES-1Mlm2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1rLZWlEPTB;MUCxMlc3OiEQvF2=NXv1RpdiW0GQR1XS
KE-37MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHzBTWJKSzVyPUGwNk46PSEQvF2=NYSyd3liW0GQR1XS
MKN45M2jh[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYPJR|UxRTFyMz61PFQh|ryPNHfFNWZUSU6JRWK=
UM-UC-3MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3\pVWlEPTB;MUCzMlg1OiEQvF2=NIXDWnZUSU6JRWK=
SNU-C2BMVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYHiTJZMUUN3ME2xNFUvODJ|IN88US=>MV7TRW5ITVJ?
RPMI-8226M2G2NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3f2NWlEPTB;MUC2MlY4QCEQvF2=M33U[3NCVkeHUh?=
PANC-08-13M3:xb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlfsTWM2OD1zME[uPFUh|ryPMoH5V2FPT0WU
NCI-H23NXvC[YhbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIP6TIVKSzVyPUGwPE4{PTdizszNM4L3NnNCVkeHUh?=
HOP-92MnWyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlfPTWM2OD1zMEiuOFc2KM7:TR?=NHrzUVhUSU6JRWK=
FTC-133MlfqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWXUfmtOUUN3ME2xNFgvPDh6IN88US=>NVnTcFRxW0GQR1XS
D-263MGNFu1XZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXnJR|UxRTFyOD65OlEh|ryPMl:2V2FPT0WU
DU-145NIfDVndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3Lj[WlEPTB;MUC5Mlk1PSEQvF2=MoOwV2FPT0WU
A253NFvXfIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2HJ[GlEPTB;MUGwMlQ4QSEQvF2=NVj2VVRDW0GQR1XS
HCT-15M335[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFTDcIdKSzVyPUGxNE43PjFizszNMYrTRW5ITVJ?
WSU-NHLMXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXPJR|UxRTFzMj6wNUDPxE1?Mni2V2FPT0WU
U031NILRS3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIj2NZpKSzVyPUGxNk4xPjVizszNNHfBZ5FUSU6JRWK=
MDA-MB-157MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHjycVVKSzVyPUGxNk41QSEQvF2=Mon4V2FPT0WU
NEC8MlrXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXfIXHZNUUN3ME2xNVIvPjJ2IN88US=>NX;iUFRjW0GQR1XS
SIG-M5NVjrVZpHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVnJR|UxRTFzMz6xNlUh|ryPNWPvVVFYW0GQR1XS
786-0M{H4Omdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoXGTWM2OD1zMUOuOFU{KM7:TR?=MYjTRW5ITVJ?
DMS-273M1zHWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MW\JR|UxRTFzNT62NVch|ryPMnH2V2FPT0WU
Calu-6NFi1epBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVuyXVQxUUN3ME2xNVYvPzl6IN88US=>NF36WVRUSU6JRWK=
HCC1599MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUjOOVNtUUN3ME2xNVcvOTV4IN88US=>NFrBco1USU6JRWK=
OVCAR-8MoXQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV24[lRsUUN3ME2xNVcvPjZ6IN88US=>MU\TRW5ITVJ?
ATN-1M1zKe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYWxPIdCUUN3ME2xNVcvQDJ6IN88US=>MnjZV2FPT0WU
RKONWe2ZpVLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVrJR|UxRTFzNz64PVgh|ryPNUTDVW9FW0GQR1XS
SKG-IIIaMmf3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{\JNGlEPTB;MUG4MlEyPiEQvF2=NYPWU4dVW0GQR1XS
SUP-T1MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXzHU2g{UUN3ME2xNVgvQTV4IN88US=>NFHOfGlUSU6JRWK=
KNS-81-FDM4nabGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkjDTWM2OD1zMUmuOFE4KM7:TR?=NHPLXWtUSU6JRWK=
OVCAR-3NGnIV5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2nDPWlEPTB;MUG5MlkyPSEQvF2=NXnhTVBoW0GQR1XS
NCI-N87Mn70S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVzaN4R[UUN3ME2xNlEvODR2IN88US=>M3;IR3NCVkeHUh?=
HuP-T4MnW1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFzaW4pKSzVyPUGyNU42PSEQvF2=M{PpUXNCVkeHUh?=
KYSE-140M3zDbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEnFT3BKSzVyPUGyNk4yPDFizszNMXzTRW5ITVJ?
HAL-01NXfsT|dET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFvWeGVKSzVyPUGyNk41QTlizszNM1yybHNCVkeHUh?=
HT-29M1nLcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoPmTWM2OD1zMkKuO|c5KM7:TR?=MXHTRW5ITVJ?
OPM-2NHfl[YNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXXJR|UxRTF{Mz6xO|Yh|ryPMnjkV2FPT0WU
SW1463MkLyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnqxTWM2OD1zMkSuNFc4KM7:TR?=MYfTRW5ITVJ?
NCI-H2087NXvRc5FUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXPJR|UxRTF{ND6yPFMh|ryPM4DjWHNCVkeHUh?=
UMC-11NHTpe3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXX4TmcyUUN3ME2xNlYvODN6IN88US=>MlHqV2FPT0WU
EB-3MlPrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFL5VllKSzVyPUGyO{4xOTNizszNMVTTRW5ITVJ?
HEC-1M{jLXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1XKO2lEPTB;MUK5MlE6QCEQvF2=NG\kNWZUSU6JRWK=
LU-99AMljZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{DCUGlEPTB;MUK5Mlk{OSEQvF2=MWHTRW5ITVJ?
VMRC-RCZNXPW[olbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4jXe2lEPTB;MUOwMlM4PSEQvF2=NFq2RZVUSU6JRWK=
MFH-inoMmHUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYfJR|UxRTF|MT6xNVQh|ryPNGHNT|ZUSU6JRWK=
HT-1080NHr2NIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFroU4VKSzVyPUGzNk4zODRizszNNHH3cVZUSU6JRWK=
CTB-1NX7BR45OT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV\JR|UxRTF|Mj64PVch|ryPM{LwW3NCVkeHUh?=
Capan-2NFj3[npIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVzjXlJoUUN3ME2xN|MvQTd3IN88US=>Ml\XV2FPT0WU
BB30-HNCNXnmSlhPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2r2c2lEPTB;MUO0MlEyPiEQvF2=M2XBXXNCVkeHUh?=
CP50-MEL-BMoXMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NI\6cIdKSzVyPUGzOE4zKM7:TR?=M1rLTHNCVkeHUh?=
JEG-3NWe3cGNwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUPJR|UxRTF|ND6zOVkh|ryPNUfLVm4yW0GQR1XS
NCI-H1437MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEj0eplKSzVyPUGzOE42QSEQvF2=NE\Ld2lUSU6JRWK=
NOS-1NUTrSppTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmTXTWM2OD1zM{SuO|Y2KM7:TR?=NYjweodNW0GQR1XS
G-402MoXVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVLJR|UxRTF|NT6yPVUh|ryPNEK2dZJUSU6JRWK=
OAW-42NGKwTmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4D4bGlEPTB;MUO3Mlg2PiEQvF2=NVL0WHIxW0GQR1XS
Ca-SkiNYLE[ZJET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1OyN2lEPTB;MUO4Mlg{OSEQvF2=NHSy[4lUSU6JRWK=
BHT-101NHHhbnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUfZU5k3UUN3ME2xOFAvOjB6IN88US=>NFz4R41USU6JRWK=
OVCAR-4M2r0cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVHn[WJRUUN3ME2xOFAvPzR7IN88US=>M2\BdHNCVkeHUh?=
Detroit562NVzROmI1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXzJR|UxRTF2MT60OlYh|ryPMV\TRW5ITVJ?
OCI-AML2NXP1[IJ[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUnJR|UxRTF2MT61NFch|ryPMUTTRW5ITVJ?
OE33NHfhR5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2rZT2lEPTB;MUSxMlc6QCEQvF2=M1jDO3NCVkeHUh?=
YKG-1NFTaXGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn3pTWM2OD1zNEKuPFg6KM7:TR?=MWDTRW5ITVJ?
CCF-STTG1Mk\DS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MULJR|UxRTF2Mz6zN|Qh|ryPM2XFRnNCVkeHUh?=
NCI-H810NWXOWmdjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnT0TWM2OD1zNEOuOlg4KM7:TR?=Mn;WV2FPT0WU
SCC-25M{TFd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlO5TWM2OD1zNESuNFA2KM7:TR?=MY\TRW5ITVJ?
HTC-C3MmnLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYDJR|UxRTF2NT6wO|Uh|ryPMXXTRW5ITVJ?
G-401MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXXJR|UxRTF2NT64N|Uh|ryPMn3EV2FPT0WU
OMC-1M2HROWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkHGTWM2OD1zNEWuPVY4KM7:TR?=MlfJV2FPT0WU
LK-2MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVLJR|UxRTF2Nz6xOFMh|ryPNEDw[lhUSU6JRWK=
SW13NYjNO4w6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXL4OGR[UUN3ME2xOFcvOjV|IN88US=>MlG5V2FPT0WU
BB49-HNCMoC4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2jUOmlEPTB;MUS3MlQxPCEQvF2=NViybZV3W0GQR1XS
DMS-114M3L0fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV2wdWJGUUN3ME2xOFcvPDRzIN88US=>Mm\0V2FPT0WU
GCIYNIPqcoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYrJR|UxRTF2Nz63PVch|ryPNGPwVmJUSU6JRWK=
GAMGMkHNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV[3SpVOUUN3ME2xOFgvOjR5IN88US=>Mln4V2FPT0WU
KYSE-520NXvSRZF[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYnpb2FYUUN3ME2xOFgvPTRizszNM3\Ce3NCVkeHUh?=
LB647-SCLCNFfWe4RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2\zU2lEPTB;MUS4MlU3OiEQvF2=NVq2elFpW0GQR1XS
639-VNYKwUG5nT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWn5SXlOUUN3ME2xOFgvPzB3IN88US=>NV;idY5yW0GQR1XS
TE-9MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3nNeGlEPTB;MUS5MlQ1OyEQvF2=MkDtV2FPT0WU
Caov-3MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFn6VldKSzVyPUG0PU44OTRizszNNIX2b2JUSU6JRWK=
L-540MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2TWTmlEPTB;MUS5Mlc2KM7:TR?=MnfxV2FPT0WU
NCI-H748NXuzWHJ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWTJR|UxRTF3MD6yNFkh|ryPNXnQSJRIW0GQR1XS
GDM-1M2HmPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV3aVWplUUN3ME2xOVEvOTN3IN88US=>MUfTRW5ITVJ?
GAKNUDIdpU4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUXJR|UxRTF3MT6zO|Qh|ryPNHe4VGVUSU6JRWK=
AsPC-1NIjNWXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV:2TIxKUUN3ME2xOVIvPzZ2IN88US=>MkPSV2FPT0WU
MDA-MB-361M4q4RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmT4TWM2OD1zNUOuNVY1KM7:TR?=M3;5OnNCVkeHUh?=
TTMWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGW3UHFKSzVyPUG1N{41QSEQvF2=M4XlSnNCVkeHUh?=
Calu-1NGLvZXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUe5TZRYUUN3ME2xOVQvODB|IN88US=>M36yVnNCVkeHUh?=
RERF-LC-MSM2e4WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVXUPFNlUUN3ME2xOVQvPzd{IN88US=>MYTTRW5ITVJ?
DK-MGMVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NY\s[2R4UUN3ME2xOVUvOTh|IN88US=>NX7WZYMxW0GQR1XS
CAL-120MoPMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIPYfFFKSzVyPUG1OU45OjFizszNM2nERXNCVkeHUh?=
HCC1419Mlf0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4HDeGlEPTB;MUW2MlA4PyEQvF2=NEG1PWZUSU6JRWK=
DG-75NWfQe2o5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYnaUVdOUUN3ME2xOVYvPjl2IN88US=>MXrTRW5ITVJ?
HCC38Mni2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnHlTWM2OD1zNUeuN|Y6KM7:TR?=M{PuNnNCVkeHUh?=
HCC70NXfVPWRNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mk\mTWM2OD1zNUmuNlQzKM7:TR?=NFyxbI1USU6JRWK=
ES4MkT5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYHJR|UxRTF3OT6zPVYh|ryPM3rKSXNCVkeHUh?=
NCI-H2052NHrQZ5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1O5VWlEPTB;MUW5MlU5OyEQvF2=NWLVUI9xW0GQR1XS
EFO-27MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXzOUmNkUUN3ME2xOlAvPTh2IN88US=>M{HXbXNCVkeHUh?=
CAL-62NXjIVIlrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH\1eoNKSzVyPUG2Nk43OTNizszNNGq4T4NUSU6JRWK=
CHP-212NEW5T2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUTJR|UxRTF4Mz62NlYh|ryPNVT2TJZiW0GQR1XS
AU565NI\tNmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkDXTWM2OD1zNkOuOlQh|ryPNIPaZY1USU6JRWK=
Ca9-22M2jhSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEPRZ2pKSzVyPUG2OE4{OjFizszNNVrQVYlIW0GQR1XS
EFO-21M1zVfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M33zNWlEPTB;MU[1MlQ2KM7:TR?=MXfTRW5ITVJ?
KINGS-1NWf6NJpnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVTGN3ZxUUN3ME2xOlcvOzV2IN88US=>MXLTRW5ITVJ?
JVM-2MoLrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYPyeXdlUUN3ME2xOlcvPDVzIN88US=>NV\VTmw2W0GQR1XS
OVCAR-5MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3O3UWlEPTB;MU[4MlMxQSEQvF2=M2fhdXNCVkeHUh?=
Calu-3M170bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoHvTWM2OD1zNkiuN|EyKM7:TR?=MYnTRW5ITVJ?
CP66-MELMXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYHJR|UxRTF4OD60NVUh|ryPMWTTRW5ITVJ?
KYSE-150MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmXWTWM2OD1zNkmuOlM3KM7:TR?=MoP6V2FPT0WU
DaoyM3jGbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEjzNXlKSzVyPUG2PU45QTFizszNMkjGV2FPT0WU
HUTU-80MonNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYfJR|UxRTF5MT6wN|Ih|ryPNGjteHhUSU6JRWK=
SW620MknnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlPFTWM2OD1zN{GuOVM2KM7:TR?=MkPOV2FPT0WU
HuO-3N1M3K4dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFnWfpdKSzVyPUG3Nk4zPzNizszNNUf1N5BpW0GQR1XS
HHMnfpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mm\TTWM2OD1zN{OuPFQ5KM7:TR?=M1\RbHNCVkeHUh?=
ME-180NFfPSWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1r6Z2lEPTB;MUe0MlAyPiEQvF2=NVvSeFRpW0GQR1XS
SW756MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn;HTWM2OD1zN{SuPFY{KM7:TR?=NHmx[IFUSU6JRWK=
LNCaP-Clone-FGCNIPnOmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NELrOG9KSzVyPUG3OU45PjFizszNMmLrV2FPT0WU
YTMUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXPzc|JxUUN3ME2xO|YvOzl7IN88US=>Mnu5V2FPT0WU
EW-3NHTkZ3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{n0dWlEPTB;MUe2MlU2PSEQvF2=Mm[4V2FPT0WU
COLO-741MnzIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYL5eoo{UUN3ME2xO|cvPTZzIN88US=>MVjTRW5ITVJ?
SK-NEP-1MoP2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEPX[3NKSzVyPUG3O{45ODZizszNMXvTRW5ITVJ?
NB10MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX3JR|UxRTF5Nz64OFYh|ryPMVXTRW5ITVJ?
SF126M3;tOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVrQZYhqUUN3ME2xO|kvPDN{IN88US=>MXjTRW5ITVJ?
NCI-H522Mon6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M17hXWlEPTB;MUixMlA2QSEQvF2=MXPTRW5ITVJ?
PSN1M32zNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUX2O3p2UUN3ME2xPFEvPjZizszNMULTRW5ITVJ?
GI-ME-NM1;4R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV\JR|UxRTF6MT62O|Ih|ryPNF3Nc2ZUSU6JRWK=
SBC-5MkjXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFLMd2dKSzVyPUG4NU46OzRizszNM13IcnNCVkeHUh?=
ONS-76M1XXb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFGyNnlKSzVyPUG4Nk4{QDdizszNMlf1V2FPT0WU
LOUCYNFLXeGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoDZTWM2OD1zOEKuOlg5KM7:TR?=NXrvXnd3W0GQR1XS
SN12CMnOyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUfYd3ZZUUN3ME2xPFIvQDJ7IN88US=>NHOx[G1USU6JRWK=
A427NXX3UFFyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2jPNGlEPTB;MUi0MlY{OSEQvF2=M1e4dXNCVkeHUh?=
DOKMnO0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWftNIVXUUN3ME2xPFQvPjR|IN88US=>MlLZV2FPT0WU
MDA-MB-415MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4PpVmlEPTB;MUi0MlY2OSEQvF2=NGS4V|lUSU6JRWK=
MRK-nu-1MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1rieGlEPTB;MUi0Mlk4OiEQvF2=NUTBO3hFW0GQR1XS
LB2241-RCCMnLXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFjwRXBKSzVyPUG4OU4yPDVizszNMknoV2FPT0WU
NCI-H1563Mn3MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVjJR|UxRTF6NT6yNFkh|ryPMn;IV2FPT0WU
MDA-MB-453NHntT2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXjJR|UxRTF6Nj65OFEh|ryPM{\LWnNCVkeHUh?=
MONO-MAC-6Mn;LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4PUfmlEPTB;MUi3MlM6OiEQvF2=Mn7zV2FPT0WU
CAPAN-1M1nwPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWqxUHB6UUN3ME2xPFcvPDV|IN88US=>NFPFPVJUSU6JRWK=
SK-LU-1MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3nNUmlEPTB;MUi4MlQzQCEQvF2=MknFV2FPT0WU
NCI-H1299NXPCSJByT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV\JR|UxRTF6OD63NVkh|ryPNUfO[JpDW0GQR1XS
KG-1NEjMNo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFTaWIVKSzVyPUG4PU44QThizszNNITFN5pUSU6JRWK=
ETK-1MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoTpTWM2OD1zOUCuNVgyKM7:TR?=NXXabJBMW0GQR1XS
NCI-H838NWnrN2d1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3zLe2lEPTB;MUmwMlM1KM7:TR?=MV;TRW5ITVJ?
HCE-4NWrqNJhTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVrJR|UxRTF7MD65PVIh|ryPNV34c5FXW0GQR1XS
A2780MmKxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF7TcodKSzVyPUG5Nk45QTFizszNNW\je2dJW0GQR1XS
COLO-668M{Xhcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXXRS3c1UUN3ME2xPVMvOTV5IN88US=>NV3UfJhTW0GQR1XS
HGC-27MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUfwRYI6UUN3ME2xPVUvPTN6IN88US=>M3X2fXNCVkeHUh?=
SW1088NUfTPVFwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYXZW5A{UUN3ME2xPVUvPjd5IN88US=>M2LZWXNCVkeHUh?=
KOSC-2NUPqfmM{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIfKc5NKSzVyPUG5OU45OThizszNNF;0XVFUSU6JRWK=
TE-1NFjRPYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYXJR|UxRTF7Nj6yOkDPxE1?NFT1NmpUSU6JRWK=
SW780MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NInYPVZKSzVyPUG5Ok44OzRizszNMlXhV2FPT0WU
22RV1NFzpVXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4HYbGlEPTB;MUm3MlQzPCEQvF2=NUTqe2xOW0GQR1XS
IA-LMNXTSepRIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUTJR|UxRTF7Nz64NlIh|ryPNH[1OFBUSU6JRWK=
TE-5Mnr6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGHmWI1KSzVyPUG5PE4xOzNizszNMk\wV2FPT0WU
JVM-3NF3uUINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYfJR|UxRTF7OD60NVkh|ryPM1uzbXNCVkeHUh?=
HT55MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnKwTWM2OD1zOUmuNVkzKM7:TR?=MVrTRW5ITVJ?
QIMR-WILNEXBXWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1r6[WlEPTB;MkCwMlEyPiEQvF2=NGLoXFRUSU6JRWK=
SJRH30MlfHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUHJR|UxRTJyMD61NVUh|ryPMonNV2FPT0WU
COLO-679NUDuPItCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MULJR|UxRTJyMD64OVkh|ryPNGK0XWdUSU6JRWK=
MDA-MB-231M4n5OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYXJR|UxRTJyMD65NFIh|ryPMk[xV2FPT0WU
MFM-223NIfHdGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXn3N3M4UUN3ME2yNFEvPTh5IN88US=>NEnmcmhUSU6JRWK=
MFE-280M{fWd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHvFNY9KSzVyPUKwNU46PjFizszNMnL4V2FPT0WU
LAMA-84MojvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHH2NJhKSzVyPUKwNk4xPzNizszNNF3ZUI5USU6JRWK=
LS-1034NXnaV5JpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlzmTWM2OD1{MEKuOVU{KM7:TR?=NFfDeY1USU6JRWK=
NCI-H345NFXRdGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4jUbGlEPTB;MkCzMlAzPyEQvF2=NULTcWh1W0GQR1XS
KYSE-70M1TEXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEnIcFVKSzVyPUKwN{45PzlizszNNXroO|ZEW0GQR1XS
EGI-1M1zyS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEXFS|VKSzVyPUKwOE45OzNizszNM{Tpe3NCVkeHUh?=
RPMI-2650MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVHFdWxqUUN3ME2yNFUvPDZ5IN88US=>M1TuWXNCVkeHUh?=
NCI-H1651MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX\ke|FVUUN3ME2yNFYvPzNizszNNGT4fZNUSU6JRWK=
HPAF-IIM2rrRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXfJR|UxRTJyOT62O|Eh|ryPMlrtV2FPT0WU
NUGC-3NHq5doZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3PnPGlEPTB;MkC5MlY4QCEQvF2=MULTRW5ITVJ?
DJM-1MmTsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXPJR|UxRTJyOT64PVch|ryPM2i0THNCVkeHUh?=
MHH-PREB-1M2XOdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYPJR|UxRTJzMD6zPFEh|ryPNUTicZZnW0GQR1XS
EW-18M1Oye2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MorHTWM2OD1{MUCuO|Y{KM7:TR?=MV7TRW5ITVJ?
BT-20Mm\aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVO3NXBCUUN3ME2yNVAvQTh4IN88US=>M2P5PHNCVkeHUh?=
A431MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoK1TWM2OD1{MUGuNlk6KM7:TR?=NYnadlY2W0GQR1XS
TCCSUPNIrtTXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFqzb|lKSzVyPUKxNU42OzNizszNNWDIb|E2W0GQR1XS
HO-1-N-1MojsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoHKTWM2OD1{MUKuPFk1KM7:TR?=MkfBV2FPT0WU
NCI-H69M{[1[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnGzTWM2OD1{MUSuNVg2KM7:TR?=M{OzcHNCVkeHUh?=
ES7MkDUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3\hTmlEPTB;MkG0Mlg4QCEQvF2=M2r5TnNCVkeHUh?=
C3AM{TaPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEXrOJVKSzVyPUKxOU42PzVizszNMYXTRW5ITVJ?
UACC-257MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlnkTWM2OD1{MUeuOFMh|ryPM33aWnNCVkeHUh?=
DMS-153MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4HqeWlEPTB;MkG3Mlg{PiEQvF2=MWHTRW5ITVJ?
LB771-HNCNYW3NXE6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXnJR|UxRTJzNz64PVMh|ryPM3\Xd3NCVkeHUh?=
HOSMV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYPHTnpmUUN3ME2yNVgvQSEQvF2=MULTRW5ITVJ?
THP-1NYrBT4hZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX7JR|UxRTJzOT62NFYh|ryPM3\mWXNCVkeHUh?=
SCC-4NUXZWJRNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYnJR|UxRTJ{MD6zOVMh|ryPNGe0bI5USU6JRWK=
SCC-3NH33SHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYLJR|UxRTJ{MD61O|ch|ryPMoLUV2FPT0WU
BC-1NEjxdYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHfnWYFKSzVyPUKyNE44QTlizszNMYXTRW5ITVJ?
NCI-H1618NWLlXoNzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWfJR|UxRTJ{MT6wNVgh|ryPNYDWNGpLW0GQR1XS
CaR-1MkDlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYHaSFRkUUN3ME2yNlEvOjVzIN88US=>NVqxe4pjW0GQR1XS
NCI-H1355MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYHnOZppUUN3ME2yNlEvOzd5IN88US=>M3vTfHNCVkeHUh?=
NCI-H1993NEHhRXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnXtTWM2OD1{MkKuNlM6KM7:TR?=NY[4WYVPW0GQR1XS
NCI-H1623MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1fOc2lEPTB;MkKyMlM5QSEQvF2=MVnTRW5ITVJ?
AGSM1;xbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHvaPYJKSzVyPUKyNk42OjNizszNNYSx[JlHW0GQR1XS
SASM{K1UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2\3fmlEPTB;MkKzMlc6PiEQvF2=M4H0OHNCVkeHUh?=
HCC1937Ml;uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVHJR|UxRTJ{ND6zPFkh|ryPMnXnV2FPT0WU
NCI-H209NFrId4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEjVboJKSzVyPUKyOk42OyEQvF2=MV7TRW5ITVJ?
NCI-H322MMlS0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1\3W2lEPTB;MkK4MlAyQSEQvF2=MnjjV2FPT0WU
CHL-1MljJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{X1bmlEPTB;MkK4MlE{KM7:TR?=NGnKToFUSU6JRWK=
NCI-H630Mo\OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1W1VmlEPTB;MkOyMlg6PyEQvF2=NY\qTW4xW0GQR1XS
5637NYXqWGp4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1rVWWlEPTB;MkOzMlAxOyEQvF2=NYfjfIQ1W0GQR1XS
MSTO-211HMX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlK2TWM2OD1{M{OuNlc3KM7:TR?=MUPTRW5ITVJ?
YAPCM{PwOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFjQV3NKSzVyPUKzOE4zPTNizszNM3\lcXNCVkeHUh?=
SW1783NIrnUFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{fHOmlEPTB;MkO0MlQyKM7:TR?=NFX3eo9USU6JRWK=
GB-1NHmzeGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2O1SmlEPTB;MkO1MlE4PyEQvF2=NH3hW2JUSU6JRWK=
NCI-H520M1\3VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVjJR|UxRTJ|NT63OFEh|ryPNF[1dFJUSU6JRWK=
NOMO-1M1TqNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEXLOINKSzVyPUKzOk4xOiEQvF2=MnXyV2FPT0WU
NCCITM13Memdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M13WcGlEPTB;MkO2Mlg4OyEQvF2=MXfTRW5ITVJ?
SW954MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn:xTWM2OD1{M{euPFY5KM7:TR?=M1TveXNCVkeHUh?=
MOLT-4M2XDb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVTJR|UxRTJ2MT6yNFkh|ryPNHO5bXNUSU6JRWK=
EB2NXHWbJh6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NG\6N3JKSzVyPUK0NU46ODdizszNMmXQV2FPT0WU
IPC-298MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUHqVZdrUUN3ME2yOFIvODd{IN88US=>NU\zT|dkW0GQR1XS
GP5dM2r4[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnPBTWM2OD1{NEKuOlE3KM7:TR?=M{f3NnNCVkeHUh?=
HNMUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWHJR|UxRTJ2Mj65PVEh|ryPMWDTRW5ITVJ?
BFTC-909MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnHNTWM2OD1{NEOuNVE5KM7:TR?=M{PtVHNCVkeHUh?=
ES5NUG5enU3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1THSmlEPTB;MkS1MlA{QCEQvF2=M4XXdXNCVkeHUh?=
SK-HEP-1NVfwdnJtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFy2UlVKSzVyPUK0Ok4xPDNizszNM2HIOnNCVkeHUh?=
T47DMl;mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFLjbIJKSzVyPUK0O{4xOTNizszNMWDTRW5ITVJ?
KYSE-510Mn\SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXzJR|UxRTJ2Nz61NVch|ryPNIrqPINUSU6JRWK=
LC-1FMnHCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGO0T2dKSzVyPUK0PE4yPTZizszNMnrvV2FPT0WU
NCI-H1693NWH2UWY2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYm2[|Q1UUN3ME2yOFkvPDl3IN88US=>NEfnXXpUSU6JRWK=
COR-L23MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEjPS|BKSzVyPUK1NE41OTJizszNMVPTRW5ITVJ?
NCI-H2228MnGwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{T3RmlEPTB;MkWwMlg3PCEQvF2=MniyV2FPT0WU
NCI-H460Ml\GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlzQTWM2OD1{NUGuOFE4KM7:TR?=MnO0V2FPT0WU
TGBC1TKBM3\CTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFzVc|NKSzVyPUK1Nk45PzVizszNMnnRV2FPT0WU
NCI-H1304MnPhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1vwdmlEPTB;MkWzMlE2PiEQvF2=NV;0S4J3W0GQR1XS
CAL-27MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnznTWM2OD1{NUOuOFg2KM7:TR?=MX3TRW5ITVJ?
NCI-H187NFXUNWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoPWTWM2OD1{NU[uO|Yh|ryPM4W4SHNCVkeHUh?=
HSC-2NXTuXXc1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEXIOm1KSzVyPUK1PE42QDRizszNNETLeVRUSU6JRWK=
CAL-39MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFLDcXpKSzVyPUK2NE4zPzJizszNNVmwdmNnW0GQR1XS
HuH-7NInkdmpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFvETFdKSzVyPUK2NE46QTZizszNM3;Xc3NCVkeHUh?=
MMAC-SFNGfjcWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX7Ec5NuUUN3ME2yOlEvOTl{IN88US=>M33nNXNCVkeHUh?=
VA-ES-BJMl3FS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGjCW5VKSzVyPUK2NU46OThizszNNGe5ZVhUSU6JRWK=
A673NEO4eWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUfIe3lxUUN3ME2yOlcvODJ3IN88US=>M1jrUHNCVkeHUh?=
LU-165NH3FVHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlXSTWM2OD1{NkeuPVQyKM7:TR?=NUTSS2JkW0GQR1XS
CAL-12TMVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoTMTWM2OD1{NkiuN|Y3KM7:TR?=NXvlUHJTW0GQR1XS
RDMkXVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYDGTIZtUUN3ME2yOlkvOTF7IN88US=>MYnTRW5ITVJ?
MDA-MB-468NETHNYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NED0WWxKSzVyPUK2PU4{OzNizszNMoX0V2FPT0WU
LN-405NEi5fWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVX4S2dVUUN3ME2yOlkvPzB6IN88US=>M4DIS3NCVkeHUh?=
MHH-CALL-2MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYDJSopXUUN3ME2yOlkvQTJizszNMknDV2FPT0WU
ES3NHf1SI9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFvTZlVKSzVyPUK3NE4{PThizszNM{DhWHNCVkeHUh?=
SK-MEL-3NYjqU5NkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml3wTWM2OD1{N{WuOFU4KM7:TR?=MnzsV2FPT0WU
TE-10NVfhU3g1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVPV[3A2UUN3ME2yO|YvPDN7IN88US=>MWHTRW5ITVJ?
BENMX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3XyN2lEPTB;Mke2MlQ3OSEQvF2=MVHTRW5ITVJ?
NB69NFfhXGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVj2OHlKUUN3ME2yO|cvPDB3IN88US=>NEjhcWNUSU6JRWK=
CAMA-1M3HxZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mln3TWM2OD1{N{iuNlc6KM7:TR?=NUTPSGs{W0GQR1XS
NCI-H1792NX;XemdwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{jFVmlEPTB;Mke5MlE5PyEQvF2=NIflfnlUSU6JRWK=
UACC-893M1Htcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1LDT2lEPTB;MkiwMlU1KM7:TR?=NH\BS4xUSU6JRWK=
TGWMmLSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn;lTWM2OD1{OEOuNFU5KM7:TR?=MorRV2FPT0WU
SH-4M3;I[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVPSS|RIUUN3ME2yPFMvOTJ|IN88US=>Mn7QV2FPT0WU
NCI-H2009M2G1RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn;MTWM2OD1{OEOuPVU{KM7:TR?=MoDKV2FPT0WU
T84NFGwc3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXnyTHViUUN3ME2yPFQvPjZ3IN88US=>M4TpOXNCVkeHUh?=
EW-7MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUHH[mozUUN3ME2yPFUvOjN{IN88US=>MVPTRW5ITVJ?
NCI-H1882M{TFRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlPWTWM2OD1{OE[uNFM2KM7:TR?=NXXPfmlvW0GQR1XS
GMS-10MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn\mTWM2OD1{OEeuNVg{KM7:TR?=NV\JZoR3W0GQR1XS
HC-1NYXQXpMxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1f2RWlEPTB;MkmwMlYxOiEQvF2=NYjZTnFUW0GQR1XS
ABC-1NYXr[oIzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{\tXGlEPTB;MkmxMlA3QSEQvF2=MYnTRW5ITVJ?
HuP-T3MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV;JR|UxRTJ7Mj6xOFYh|ryPMmDTV2FPT0WU
HT-1197NXLN[YU5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{DnPWlEPTB;MkmyMlg4QSEQvF2=Mn;MV2FPT0WU
SHP-77M3vST2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVPzVmR2UUN3ME2yPVUvPTl5IN88US=>MlvsV2FPT0WU
NCI-H524MkPsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHW0WWVKSzVyPUK5OU44PjlizszNMlu5V2FPT0WU
SW626MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M362cGlEPTB;Mkm2MlEyPSEQvF2=NV3JOIdPW0GQR1XS
NCI-H2347NXj6b|MxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn\MTWM2OD1{OU[uOFI2KM7:TR?=Mnz1V2FPT0WU
U251MljrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGPVb2FKSzVyPUK5PE41OzhizszNMYnTRW5ITVJ?
RL95-2NYTYfJFCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1jBSmlEPTB;M{CwMlI1PyEQvF2=MXTTRW5ITVJ?
C2BBe1NYK3SWpQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYfJR|UxRTNyMD62PVEh|ryPM4TvOXNCVkeHUh?=
HLENH21Z4tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYrHeYNVUUN3ME2zNFEvQDF6IN88US=>MULTRW5ITVJ?
COLO-680NMnmwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnKxTWM2OD1|MEKuPFk{KM7:TR?=NYL0VphQW0GQR1XS
PLC-PRF-5NYTlc|ZnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV\JR|UxRTNyND65NFch|ryPNITG[JdUSU6JRWK=
SCC-15Mon0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1LGUWlEPTB;M{C2MlAyPyEQvF2=NF3sPYdUSU6JRWK=
ECC12M{HWfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVjMXGlnUUN3ME2zNVAvOjV2IN88US=>M1vI[XNCVkeHUh?=
A388NH\ROHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4fPS2lEPTB;M{GyMlAzOiEQvF2=NGDZUXRUSU6JRWK=
ES1NHnz[I1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEXNco5KSzVyPUOxNk4yQDlizszNM1GyOnNCVkeHUh?=
J-RT3-T3-5NXfDN|V[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3G0UGlEPTB;M{GzMlUzOSEQvF2=NHrBfGtUSU6JRWK=
SNU-475MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{W2UmlEPTB;M{G0MlA6OSEQvF2=MYTTRW5ITVJ?
647-VMYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX3USJdFUUN3ME2zNVQvPjd|IN88US=>NFvoeplUSU6JRWK=
IMR-5NF;qXY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmntTWM2OD1|MUWuN|gh|ryPMkT5V2FPT0WU
EW-24Mn34S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFnFWHJKSzVyPUOyNE4xPyEQvF2=MkL3V2FPT0WU
CAL-51MoH6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4\LdmlEPTB;M{KxMlQxOyEQvF2=MW\TRW5ITVJ?
HD-MY-ZNV7vNZh6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2PXfmlEPTB;M{KxMlQxQSEQvF2=M3jPbnNCVkeHUh?=
EW-13NXK2WYt{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1LDeWlEPTB;M{KyMlQzPCEQvF2=M33vOHNCVkeHUh?=
SK-N-FINInUbldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnWzTWM2OD1|MkKuOFUzKM7:TR?=MYrTRW5ITVJ?
BHYNY\WSlVQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3n1R2lEPTB;M{KzMlE4PSEQvF2=NHzC[HFUSU6JRWK=
OCUB-MNIT3[HNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkP5TWM2OD1|MkOuOFM1KM7:TR?=NUfYSY9mW0GQR1XS
HCC1954Mk\6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmL6TWM2OD1|MkOuOVgzKM7:TR?=NFzwbnZUSU6JRWK=
SK-MEL-24M{\rdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4fITGlEPTB;M{K0MlEyOSEQvF2=MXLTRW5ITVJ?
NTERA-S-cl-D1NXXKSpRQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3HuNGlEPTB;M{K2MlQ5QSEQvF2=MWnTRW5ITVJ?
SK-MEL-30M2LJ[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYXJR|UxRTN{Nj63N|gh|ryPM2rsVnNCVkeHUh?=
LS-123MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MW\JR|UxRTN{OD6xOlQh|ryPM2r5PXNCVkeHUh?=
SF268MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoHyTWM2OD1|M{CuNlY2KM7:TR?=NXz5No9sW0GQR1XS
BT-474MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIjTRpVKSzVyPUOzNk41OThizszNNXG3XHBbW0GQR1XS
NCI-H1522NEDX[GNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkHSTWM2OD1|M{SuN|M6KM7:TR?=MkXjV2FPT0WU
LC-2-adNIfFfVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHnpdVRKSzVyPUOzOk42QTFizszNMkDaV2FPT0WU
LAN-6MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYHweHVkUUN3ME2zN|YvQTd5IN88US=>NFq0bXhUSU6JRWK=
ARH-77MlLyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2rwemlEPTB;M{O3MlMzKM7:TR?=MUfTRW5ITVJ?
HuO9MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHmzdHZKSzVyPUOzO{41PyEQvF2=NGrsN3pUSU6JRWK=
MLMANXvLe4lrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVTJR|UxRTN|OD6xOVUh|ryPNGLYSI1USU6JRWK=
RajiMkDqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnPwTWM2OD1|M{iuN|gh|ryPMoHGV2FPT0WU
GT3TKBMoXaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnfBTWM2OD1|M{iuOFEzKM7:TR?=NHnQWYVUSU6JRWK=
NCI-H441MmTzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIHtPGxKSzVyPUO0NU41OThizszNMlHCV2FPT0WU
NCI-H2030M1XBXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3nDUGlEPTB;M{SxMlYxQSEQvF2=NI\oSplUSU6JRWK=
VM-CUB-1NIHhcWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkG2TWM2OD1|NEKuOlM3KM7:TR?=NHHlRllUSU6JRWK=
KP-4NXnaUHdkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmHlTWM2OD1|NEOuO|M{KM7:TR?=M{jUcXNCVkeHUh?=
PF-382NGL3dm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NY\SW2c4UUN3ME2zOFQvPDJ{IN88US=>M2iyeXNCVkeHUh?=
NB13MluzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWnJR|UxRTN2NT61PEDPxE1?NHyx[odUSU6JRWK=
D-502MGM4DIcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MW\JR|UxRTN2NT64NVIh|ryPMk\DV2FPT0WU
CAL-54NEDYS2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGG5N2FKSzVyPUO0OU45PzlizszNMmrFV2FPT0WU
DOHH-2MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUHJR|UxRTN2Nj62OUDPxE1?MYXTRW5ITVJ?
SK-PN-DWM3PYTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWTJR|UxRTN2Nz60NlYh|ryPMUnTRW5ITVJ?
NCI-H720MlL4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1nydmlEPTB;M{S5Mlg1PiEQvF2=NUPUV3VKW0GQR1XS
SW1990NFzlUXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnXVTWM2OD1|NUGuNlgh|ryPMWnTRW5ITVJ?
NCI-H2196Mn;DS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NY[wcFg1UUN3ME2zOVIvPjJ2IN88US=>M3rSenNCVkeHUh?=
P30-OHKMnXTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXnmWXg4UUN3ME2zOVMvODZ|IN88US=>NGfsSnVUSU6JRWK=
NCI-H358MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVXJR|UxRTN3NT6zOVYh|ryPMYjTRW5ITVJ?
CW-2NWL2TYM{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWXJR|UxRTN3Nj61Nlkh|ryPNILPW4pUSU6JRWK=
COLO-678M{TXNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml3lTWM2OD1|NUeuPFY{KM7:TR?=NYHDcWtpW0GQR1XS
NCI-H2126M{TIXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYf3T5Q5UUN3ME2zOVgvPTJzIN88US=>NFq5[ZpUSU6JRWK=
DMS-53M3fZZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUXJR|UxRTN3OD63NVEh|ryPMnfhV2FPT0WU
NCI-H1838NEiyVnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Moe4TWM2OD1|NUmuPVg4KM7:TR?=MWTTRW5ITVJ?
SJSA-1NXTNOWJbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVPheWRjUUN3ME2zOlAvQTN7IN88US=>NUfqeYJPW0GQR1XS
ChaGo-K-1NUTPVG5yT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXjkOmRuUUN3ME2zOlMvQTJ2IN88US=>NUjPfoQ6W0GQR1XS
IST-SL2M2Xx[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWf3[ZRsUUN3ME2zO|IvQTJ4IN88US=>MXPTRW5ITVJ?
U-266M1:1RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlTtTWM2OD1|N{OuNVMzKM7:TR?=MYfTRW5ITVJ?
P31-FUJNF7EbHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M17oXWlEPTB;M{e2Mlk3PCEQvF2=MYjTRW5ITVJ?
HCC2157MlOwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3LtTWlEPTB;M{e4MlE3OSEQvF2=NIOyTolUSU6JRWK=
COR-L88MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVHJR|UxRTN6Mz62O|ch|ryPMYfTRW5ITVJ?
NCI-H596M3\MWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHu4WodKSzVyPUO4OU4{PCEQvF2=NYXhS2JQW0GQR1XS
GOTOMlHxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX3JR|UxRTN7MD62OFEh|ryPNHO0NYNUSU6JRWK=
NCI-H719MlWwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUe2bm9GUUN3ME2zPVEvQDl|IN88US=>MoHwV2FPT0WU
MN-60NHLDfG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1nne2lEPTB;M{mzMlk1QCEQvF2=M3;4c3NCVkeHUh?=
IST-SL1MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mnz5TWM2OD1|OUSuOFA3KM7:TR?=NGrldnhUSU6JRWK=
TE-6NES0S2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlLETWM2OD1|OUeuNlU1KM7:TR?=NXPOSotYW0GQR1XS
SW962NXrt[mpKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF[zXlFKSzVyPUO5PE43QSEQvF2=MoOzV2FPT0WU
FADUMX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1Hr[2lEPTB;NECzMlA5OyEQvF2=NYnmNJAzW0GQR1XS
ECC4Ml3mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmXjTWM2OD12MEiuOFU5KM7:TR?=MVLTRW5ITVJ?
MES-SANVS3N4piT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYq0V4ExUUN3ME20NFkvQThizszNNGLmTGFUSU6JRWK=
NCI-H716M4W4c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoXyTWM2OD12MUCuNFc2KM7:TR?=M3[1cnNCVkeHUh?=
GR-STM2nI[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MofWTWM2OD12MUCuOFk4KM7:TR?=NF\peWdUSU6JRWK=
KY821M4LTUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIfucWFKSzVyPUSxOE4xQDZizszNMmixV2FPT0WU
NCI-H2141NYjhVldLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFTBd|lKSzVyPUSyOE4{QDhizszNMoPJV2FPT0WU
MDA-MB-134-VIMWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2H5VWlEPTB;NEOxMlA{OyEQvF2=NFTHXZpUSU6JRWK=
RH-1M{fV[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn23TWM2OD12M{WuNFkh|ryPMYTTRW5ITVJ?
AM-38MoT4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVP3e2tLUUN3ME20N|gvPTRizszNNULvXI1IW0GQR1XS
BL-70MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH3rPXhKSzVyPUSzPU41OjlizszNM1PGO3NCVkeHUh?=
COLO-684NWD3WG1UT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHfZUIlKSzVyPUS0PE45QDhizszNM2jn[3NCVkeHUh?=
DMS-79MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXHydm5vUUN3ME20OFkvPjhizszNMXfTRW5ITVJ?
EW-1MljaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVuyenI{UUN3ME20OVIvQDh6IN88US=>NGTNeVZUSU6JRWK=
MS-1NFizZ2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUjJR|UxRTR3ND6zPFUh|ryPM3LYSXNCVkeHUh?=
A4-FukMmrWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MorXTWM2OD12NUSuOVA4KM7:TR?=NEjrSpZUSU6JRWK=
TALL-1MmjmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXfJR|UxRTR3NT6yPVch|ryPM4PuV3NCVkeHUh?=
SCLC-21HMWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlTOTWM2OD12NUWuOlk6KM7:TR?=M4TmUnNCVkeHUh?=
KMS-12-PENYrjd4pnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWDiOHBtUUN3ME20OVYvQDJ{IN88US=>MX7TRW5ITVJ?
TE-441-TNYTxeFNLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3GyRWlEPTB;NEW3MlE5PiEQvF2=Mo\MV2FPT0WU
A3-KAWMlnmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV;JR|UxRTR4MD64OFEh|ryPNX6zPGZlW0GQR1XS
NCI-H1092NGnMdGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX;Vc3pbUUN3ME20OlMvQTR|IN88US=>NHz3R|FUSU6JRWK=
COR-L279NEHLXIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVHYcJhpUUN3ME20OlQvQDR5IN88US=>M{nITHNCVkeHUh?=
NCI-SNU-5MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX3JR|UxRTR5Mj6yPEDPxE1?MmTnV2FPT0WU
JARNGC3[mNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUnRcFhpUUN3ME20O|QvPzh6IN88US=>M4jaOnNCVkeHUh?=
NCI-H446MoHvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX\Mb4sxUUN3ME20O|cvODhizszNNUXX[XUyW0GQR1XS
HDLM-2NWLibmxzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{jsXGlEPTB;NEiwMlg3QSEQvF2=NEPKS|lUSU6JRWK=
D-283MEDNWSyOY5ZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFvNd2xKSzVyPUS4PE46OjRizszNMV;TRW5ITVJ?
NCI-H1395NFT2R2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2\PVWlEPTB;NEi5MlAxPCEQvF2=MmLtV2FPT0WU
RPMI-6666MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFjhNmRKSzVyPUS5NU4{QThizszNMYfTRW5ITVJ?
CPC-NM3HBSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXvLUlZvUUN3ME21NFIvODZ|IN88US=>NFm0U4FUSU6JRWK=
EC-GI-10MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml\iTWM2OD13MEKuNVY6KM7:TR?=MkHyV2FPT0WU
CA46NUPEOmlvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEjGT5ZKSzVyPUWwOE41ODdizszNNG\lSmpUSU6JRWK=
EHEBMmmxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVLBcJZpUUN3ME21NFcvOjB6IN88US=>MWHTRW5ITVJ?
RPMI-8402NHnBdFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGXyc4JKSzVyPUWxNE4xOjFizszNMVjTRW5ITVJ?
DU-4475NGLNeppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIToOZlKSzVyPUWxNU4yODFizszNMmHuV2FPT0WU
P12-ICHIKAWAM33YfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NU\2VZF7UUN3ME21NVEvPDF4IN88US=>M1vOW3NCVkeHUh?=
NCI-H1694M{HIO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHjtU3hKSzVyPUWxNk41OzlizszNMVTTRW5ITVJ?
NCI-H2171NF;iVZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3HKSmlEPTB;NUGyMlcxPSEQvF2=NFns[25USU6JRWK=
Mo-TNETJPHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MW\JR|UxRTVzNT6xNVYh|ryPMoTZV2FPT0WU
HL-60NYDKeVZwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHnJWlJKSzVyPUWyNk46OjRizszNNUjiSlVqW0GQR1XS
NCI-H1436MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlTQTWM2OD13MkOuNFY1KM7:TR?=NWWx[|R1W0GQR1XS
NCI-H510AMkfXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NETES4RKSzVyPUWyOE43QTZizszNNHy5dndUSU6JRWK=
NCI-H2081NHzoflhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFvrZVNKSzVyPUWyOU42OTNizszNNYPWfpY6W0GQR1XS
NB5NGXvPYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWK3cHhPUUN3ME21NlYvPDNizszNNEe1V3pUSU6JRWK=
NCI-H2227NXriOpc3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnHKTWM2OD13M{CuNlU1KM7:TR?=M4T2N3NCVkeHUh?=
HSC-4M4XvPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX\JR|UxRTV|OT6yPVMh|ryPNYfOU4JKW0GQR1XS
RLMXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmX4TWM2OD13NEKuOFQzKM7:TR?=MVTTRW5ITVJ?
EVSA-TMnzOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWnRd|NsUUN3ME21OFMvPjh2IN88US=>M4jiNXNCVkeHUh?=
NCI-H889NXy3foNYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlLITWM2OD13NEeuNlMh|ryPMmfDV2FPT0WU
COLO-320-HSRNInnRoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF;rb|JKSzVyPUW1NU4{PSEQvF2=NITYUVVUSU6JRWK=
EW-11M1PWXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXH1bVJjUUN3ME21OVIvOzl7IN88US=>M3XKeHNCVkeHUh?=
UACC-812M1;QdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4DX[2lEPTB;NUW5MlM6OSEQvF2=M3;6XXNCVkeHUh?=
CAL-148MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFSwTpVKSzVyPUW2OU4xQDlizszNM4XrT3NCVkeHUh?=
K052MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUHJR|UxRTV5OT6yNVMh|ryPNEfHfoNUSU6JRWK=
L-428M{nncWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVjJR|UxRTZyMD62O|Eh|ryPNVPKdYlqW0GQR1XS
LP-1NWj5OpdOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIK1bZhKSzVyPU[wN{42QDdizszNNGTMNZdUSU6JRWK=
ML-2MmD3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX\JR|UxRTZyNj61O|kh|ryPMXrTRW5ITVJ?
KARPAS-45MojUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYPPb3RUUUN3ME22NVgvOjJzIN88US=>M4j3TXNCVkeHUh?=
HTNHrrN3dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF7sO3hKSzVyPU[yNk44QDVizszNMoTxV2FPT0WU
NCI-H226NWT1R21NT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkHYTWM2OD14MkiuN|U{KM7:TR?=NYT2e4xJW0GQR1XS
L-363MlXqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWfJR|UxRTZ2OD6wOlQh|ryPMkW0V2FPT0WU
IM-9M4DqbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkDaTWM2OD14NUGuOVQyKM7:TR?=Mn\GV2FPT0WU
TURMnH2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEX0eHhKSzVyPU[3NU4{OjJizszNMXnTRW5ITVJ?
NCI-SNU-16MmnzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mnu3TWM2OD14OECuOFYzKM7:TR?=Mn3pV2FPT0WU
NCI-SNU-1MnrrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHzPN4lKSzVyPU[5NE4yPzJizszNMoLGV2FPT0WU
U-87-MGMX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWLJR|UxRTZ7ND61PFUh|ryPNFnzbWxUSU6JRWK=
KM-H2NG[xZppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXnJR|UxRTZ7OT6wOVkh|ryPMl7IV2FPT0WU
DELMmrmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmqwTWM2OD15MECuPFM5KM7:TR?=M{TOSnNCVkeHUh?=
KARPAS-422M3PS[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1KzXmlEPTB;N{i5MlMyPSEQvF2=NXfGU2l4W0GQR1XS
BC-3NGjxdXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXnJR|UxRThyNT6yNFMh|ryPNXzQXJhxW0GQR1XS
NCI-H1155NInlUGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUHJR|UxRThzOD6wOVkh|ryPM1XuSXNCVkeHUh?=
NCI-H1581NW\OdmdKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NE\zfXBKSzVyPUmwNE4zOzFizszNNXTJPFY5W0GQR1XS

... Click to View More Cell Line Experimental Data

In vivo Oral administration of CHIR-99021 at 30 mg/kg enhances glucose metabolism in a rodent model of type 2 diabetes, with a maximal plasma glucose reduction of nearly 150 mg/dl 3-4 hours after administration, while plasma insulin remains at or below control levels. Oral administration of CHIR-99021 at 16 or 48 mg/kg 1 hour before oral glucose challenges in ZDF rats significantly improves glucose tolerance with 14% and 33% reduction in plasma glucose at 16 mg/kg and 48 mg/kg, respectively, and the higher dose of CHIR-99021 also reduces hyperglycemia before the oral glucose challenge. [1] Administration of CHIR-99021 significantly augments hematopoietic repopulation in recipient mice transplanted with mouse or human hematopoietic stem cells (HSCs), suggesting that GSK-3 is a specific modulator of HSC activity. [4]
Features

Protocol(Only for Reference)

Kinase Assay:

[1]

Cell-free kinase assays Polypropylene 96-well plates are filled with 300 μL/well buffer (50 mM tris HCl, 10 mM MgCl2, 1 mM EGTA, 1 mM dithiothreitol, 25 mM β-glycerophosphate, 1 mM NaF, 0.01% BSA, pH 7.5) containing 27 nM GSK-3α or 29 nM GSK-3β, and 0.5 μM biotin-CREB peptide substrate. Various concentrations of CHIR-99021 are added in 3.5 μL of DMSO, followed by 50 μL of ATP stock to yield a final concentration of 1 μM ATP in all cell-free assays. After incubation, triplicate 100-μL aliquots are transferred to Combiplate eight plates containing 100 μL/well 50 μM ATP and 20 mM EDTA. After 1 hour, the wells are rinsed five times with PBS, filled with 200 μL of scintillation fluid, sealed, left 30 minutes, and counted in a scintillation counter. All steps are performed at room temperature.

Cell Assay:

[3]

Cell lines INS-1E
Concentrations Dissolved in DMSO, final concentrations ~ 20 μM
Incubation Time 1, or 4 days
Method

Cells are maintained for 24 hours in starvation medium (culture medium with only 5 mM glucose, 1% fetal calf serum). Then cells are exposed to various concentrations of CHIR-99021 for 1, or 4 days. Cell number is measured by staining of cellular DNA with CyQuant dye, which becomes fluorescent when bound to DNA. Fluorescence is measured after 30 minutes of incubation using the FLUOstar Optima reader. Cell replication is determined by BrdUrd incorporation. BrdUrd labeling solution is added to the medium for the last 4 hours before the cells are fixed using FixDenat solution and incubated with monoclonal anti-BrdUrd-POD antibodies. After substrate solution is added to each well, the light emission is measured in a microplate luminometer using the Analyst HT detection system.

Animal Study:

[1]

Animal Models Female db/db mice or male ZDF rats with type 2 diabetes
Formulation Formulated as solutions in 20 mM citrate-buffered 15% Captisol or as fine suspensions in 0.5% carboxymethylcellulose.
Dosages ~48 mg/kg
Administration Orally

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Ring DB, et al. Diabetes, 2003, 52(3), 588-595.

[2] Bennett CN, et al. J Biol Chem, 2002, 277(34), 30998-31004.

view more

Chemical Information

Download CHIR-99021 (CT99021) HCl SDF
Molecular Weight (MW) 501.8
Formula

C22H18Cl2N8.HCl

CAS No. 252917-06-9 (free base)
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 93 mg/mL (185.33 mM)
Ethanol 2 mg/mL (3.98 mM)
Water <1 mg/mL (<1 mM)
In vivo 15% Captisol 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 6-(2-(4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-ylamino)ethylamino)nicotinonitrile hydrochloride

Customer Product Validation(7)


Click to enlarge
Rating
Source Proc Natl Acad Sci U S A 2012 109(27):E1848-57. CHIR-99021 (CT99021) HCl purchased from Selleck
Method Immunofluorescent staining
Cell Lines H9-7TGP cells
Concentrations 12 uM
Incubation Time 4 days
Results However, treatment of the H9-7TGP reporter line with the Gsk3 inhibitor CHIR99021 (CH) activated TCF/LEF promoter activity in mTeSR1 on Matrigel. Immunofluorescent analysis revealed that the CH-induced H9-7TGP GFP+ cells did not express Oct4 but did express Isl1 and Nkx2.5.

Click to enlarge
Rating
Source Stem Cells 2012 30, 1863-1874. CHIR-99021 (CT99021) HCl purchased from Selleck
Method beating foci assay
Cell Lines ESCs
Concentrations 1/3uM
Incubation Time 5 d
Results Similarly, inhibition of GSK3 by LiCl [48], by CHIR 99021 [7], or by AR A014418 (a GSK3 inhibitor, which lacks side effects as impairment of cyclin functions [49]), restored the differentiation potential of Gpc4-mutant ESCs to a similar extent.

Click to enlarge
Rating
Source J Biol Chem 2015 290(9), 5592-605 . CHIR-99021 (CT99021) HCl purchased from Selleck
Method Immunofluorescence
Cell Lines PANC1 cells
Concentrations 5 uM
Incubation Time 24 h
Results As shown in D, LC3B puncta were detected in DMSO treated (control) pancreatic cancer cells suggestive of a high degree of autophagy in these cells. This observation is in agreement with a previous report demonstrating an elevated level of autophagy in human pancreatic cancer cell lines that is required for their growth. Despite the high level of basal autophagy, an increased staining of LC3B puncta per cell was observed upon treatment with CHIR99021 or the mTOR inhibitor Torin1 (D), the latter being used as a known inducer of autophagy. For completion of autophagy, the autophagosomes ultimately fuse with lysosomes to ensure the degradation of autophagosomal content. We therefore examined the lysosomal system by performing labeling of these organelles with Lysotracker. CHIR99021 led to an increase in lysosomal staining (E).

Click to enlarge
Rating
Source J Genet Genomics 2012 39, 643e651. CHIR-99021 (CT99021) HCl purchased from Selleck
Method Rat embryoid bodies (rEBs) formation
Cell Lines rES cells
Concentrations 0.75 uM
Incubation Time 4 d
Results For the first 2 days of rEBs formation, rES cells were cultured in CM in the presence of Rho kinase inhibitor, Y-27632 (10 umol/L) and 2i (PD0325901, 0.1 umol/L; CHIR99021, 0.75 umol/L; Selleck, USA). Thereafter, we transferred the regular rEBs into CM supplemented with 2i and without Y-27632 for another 2 days. On day 4, abundant highquality rEBs formed and then 2i was eliminated from the media.

Click to enlarge
Rating
Source PLoS One 2012 7, e47312. CHIR-99021 (CT99021) HCl purchased from Selleck
Method Westernblot
Cell Lines WM793/1205LU
Concentrations 2 uM
Incubation Time 2 h
Results Phoshorylation of β-catenin is decreased and total b-catenin level is slightly increased as a result of CT99021 2-hour treatment.

Click to enlarge
Rating
Source CHIR-99021 (CT99021) HCl purchased from Selleck
Method Western blot
Cell Lines PANC1 cells
Concentrations 5 µM
Incubation Time 72 h
Results prolonged inhibition of GSK3 expression or activity by CHIR99021 correlated with increased levels of cleaved PARP and caspase-7 as well as a 6-fold increase in caspase-3 activity.

Click to enlarge
Rating
Source CHIR-99021 (CT99021) HCl purchased from Selleck
Method Western blot/qRT-PCR analysis
Cell Lines Human lung tissue
Concentrations 0.5/10 μM
Incubation Time 72 h
Results As presented in Figure 6 and B, Western blot analysis showed β-CATENIN expression in 15 W human lung explants decreased significantly from newly isolated to in vitro cultured for 72 h (0 μM). However, β-CATENIN expression nearly increased back to newly isolated levels in human lung explants at 15 W treated with 5 μM CHIR 99021 for 72 h, but decreased again after treatment of 10 μM CHIR 99021. Meanwhile, qRT-PCR analyses showed increased expression of transcription factors (LEF1 , TCF4) and target genes (CYCLIN D1 , MMP7) in human lung explants (15 W) exposed to 5 μM CHIR 99021 compared with tissues exposed to 0 μM CHIR 99021, the levels of which were also higher than in the 10 μM CHIR 99021 groups (Figure C).

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related GSK-3 Products

  • CHIR-99021 (CT99021)

    CHIR-99021 (CT99021) is a GSK-3α and GSK-3β inhibitor with IC50 of 10 nM and 6.7 nM, respectively.

  • LY2090314

    LY2090314 is a potent GSK-3 inhibitor for GSK-3α/β with IC50 of 1.5 nM/0.9 nM; may improve the efficacy of platinum-based chemotherapy regimens. Phase 2.

  • TDZD-8

    TDZD-8 is a non-ATP competitive GSK-3β inhibitor with IC50 of 2 μM; minimal inhibitory effect observed on CDK1, casein kinase II, PKA and PKC.

  • TWS119

    TWS119 is a GSK-3β inhibitor with IC50 of 30 nM in a cell-free assay; capable of inducing neuronal differentiation and may be useful to stem cell biology.

  • SB216763

    SB216763 is a potent and selective GSK-3 inhibitor with IC50 of 34.3 nM for GSK-3α and equally effective at inhibiting human GSK-3β.

  • Tideglusib

    Tideglusib is an irreversible, non ATP-competitive GSK-3β inhibitor with IC50 of 60 nM in a cell-free assay; fails to inhibit kinases with a Cys homologous to Cys-199 located in the active site. Phase 2.

  • CHIR-98014

    CHIR-98014 is a potent GSK-3α/β inhibitor with IC50 of 0.65 nM/0.58 nM in cell-free assays, with the ability to distinguish GSK-3 from its closest homologs Cdc2 and ERK2.

  • BIO

    BIO is a specific inhibitor of GSK-3 with IC50 of 5 nM for GSK-3α/β in a cell-free assay, shows >16-fold selectivity over CDK5, also a pan-JAK inhibitor.

    Features:The first pharmacological agent shown to maintain self-renewal in human and mouse embryonic stem cells.

  • AR-A014418

    AR-A014418 is an ATP-competitive, and selective GSK3β inhibitor with IC50 and Ki of 104 nM and 38 nM in cell-free assays, without significant inhibition on 26 other kinases tested.

  • IM-12

    IM-12 is a selective GSK-3β inhibitor with IC50 of 53 nM, and also enhances canonical Wnt signalling.

Recently Viewed Items

Tags: buy CHIR-99021 (CT99021) HCl | CHIR-99021 (CT99021) HCl supplier | purchase CHIR-99021 (CT99021) HCl | CHIR-99021 (CT99021) HCl cost | CHIR-99021 (CT99021) HCl manufacturer | order CHIR-99021 (CT99021) HCl | CHIR-99021 (CT99021) HCl distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us